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The International Laboratory for Research on Animal Diseases (ILRAD) was established in
1973 with a mandate to develop effective control measures for livestock diseases which
seriously limit world food production. ILRAD's research program focuses on African animal
trypanosomiasis and East Coast fever, a form of the theileriosis.
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Foreword
The International Laboratory for Research on Animal Diseases (ILRAD) was established in
1973 with a mandate to develop effective control measures for livestock diseases which
seriously limit world food production. ILRAD's research programs focus on African animal
trypanosomiasis and East Coast fever (ECF), a form of theileriosis. These two disease
complexes are a serious constraint on livestock production and rural economic development in
Africa and other tropical regions, causing direct and indirect economic losses and human
suffering over substantial areas.
There are unlikely to be any quick or easy solutions for improving the control of animal
trypanosomiasis or theileriosis. The complexity of these animal health problems has been
recognized for many years. A major research effort is required to improve our understanding
of the protozoan parasites which cause these diseases, of the disease processes and
responses of affected livestock and of ways to prevent or reduce further losses.
To meet these needs, ILRAD has steadily increased its capacity to carry out scientific
research, starting in 1975 with the construction of basic facilities at Kabete on the outskirts of
Nairobi, Kenya, and the arrival of a small nucleus of scientific staff. In 1985, ILRAD occupied a
complex of research laboratories and support units, including a cattle breeding ranch at Kapiti
about 80 km from Nairobi, and was staffed by a full complement of 50 internationally recruited
scientists and associated specialists, with appropriate supporting personnel.
Research programs at Kabete are complemented by collaborative research agreements with
laboratories in Africa and other parts of the world. ILRAD has developed important contacts
with national research systems in many African countries affected by trypanosomiasis and
theileriosis—through collaborative research networks, scientific meetings, training activities
and the distribution of research reports. ILRAD also maintains close contact with international
organizations and bilateral technical assistance agencies concerned with animal disease
control and agricultural development. These include the World Bank (International Bank for
Reconstruction and Development—IBRD), the Food and Agriculture Organization of the
United Nations (FAO), the United Nations Development Program (UNDP), the World Health
Organization (WHO), the Organization of African Unity (OAU) and the International Livestock
Centre for Africa (ILCA).
As one of 13 international agricultural research centres supported by the Consultative Group
on International Agricultural Research (CGIAR), ILRAD is subject to external program and
management reviews every 5 years. Late in 1985 and extending into January 1986, all
aspects of ILRAD's research and training programs were reviewed by panels of scientific and
administrative specialists commissioned by the CGIAR. Professor Jos Mortelmans of the
Prince Leopold Institute of Tropical Medicine (Belgium) was chairman of the External Program
Review panel, and Mr Frank Raymond, former Chief Scientist in the Ministry of Agriculture,
Fisheries and Food (UK) headed the panel conducting the External Management Review. The
review teams concentrated on progress made since ILRAD was first reviewed in 1980. By any
standards, achievements have been substantial. Some of the highlights may be summarized
as follows:
completion of a detailed study on trypanosomiasis epidemiology at a site in Kenya's
Coast Province, with special emphasis on serodeme characterization and the possibility
of acquired immunity under chemotherapeutic treatment
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establishment of a collaborative research network with ILCA and national livestock
production services in 8 African countries to assess the productivity of trypanotolerant
livestock under different levels of trypanosomiasis risk-development of new techniques
to diagnose trypanosomiasis and determine the origin of tsetse bloodmeals
establishment of in vitro culture systems to maintain the three major pathogenic
trypanosome species for use in a variety of studies, including in vitro testing of drug
sensitivity
investigation of the genetic mechanisms underlying antigenic variation in Trypanosoma
brucei and T congolense and studies on the synthesis of variable surface antigens in T
brucei
discovery that host responses influence trypanosome differentiation from rapidly-dividing
to non-dividing bloodstream forms and that this differentiation triggers the humoral
immune response
description of the immunosuppressive effects of T brucei infection which involve
inhibition of B lymphocyte maturation and disruption of the structure of the lymph nodes
and spleen
demonstration of resistance to trypanosome infection in N'Dama calves brought to
ILRAD from The Gambia by embryo transfer and in different species of wildlife
use of monoclonal antibody technology to characterize strains of Theileria parva parva
and T p lawrencei from Kenya and other countries in eastern and southern Africa
ECF epidemiology studies and 'infection-and-treatment' immunization trials in Kenya's
Coast Province and support to national veterinary services and FAO projects conducting
related field trials in Burundi, Malawi, Rwanda, Zambia, Tanzania (Zanzibar), and
Zimbabwe
identification, isolation and characterization of Theileria sporozoite antigens which may
provide the basis for an improved vaccine
immunological and biochemical studies to identify Theileria schizont-associated antigens
which could also be used in an improved vaccine
application of recombinant DNA techniques to construct genomic and cDNA libraries
aimed at producing Theileria antigens for improved vaccines.
Important activities in 1985 included the launching of a special project within the ILCA/ILRAD
trypanotolerance network to study N'Dama cattle at several sites in The Gambia and Senegal.
This project is being conducted in cooperation with the International Trypanotolerance Centre
in The Gambia and is supported by the European Economic Community (EEC). Scientists
working in the trypanotolerance network met at ILRAD in December for a major review of
achievements and discussion of future activities.
Studies on trypanosomiasis epidemiology have indicated chromosomal differences between
isolates of T congolense which could be regarded as a basis for description of a new parasite
species. Basic research continues on trypanosome biochemistry and antigenicity, including
efforts to expand the cultivation of the three major trypanosome species in vitro. ILRAD is
collaborating with the Swiss Tropical Institute in a study to identify trypanosome growth
factors, and the Japanese International Cooperation Agency is supporting work on T brucei
cultivation through a special project. Scientists are using cell biology and immunoelectron
microscopy techniques to investigation aspects of trypanosome metabolism: the goal is to
identify vulnerable receptor mechanisms which could be blocked by chemical or
immunological means.
Studies continue on host responses which stimulate or inhibit trypanosome growth and on
parasite-induced suppression of immune responses. Material for comparative studies is
provided through collaboration with the wildlife section of the Kenya Government's Veterinary
Research Laboratory as part of a special project funded by the Government of The
Netherlands. This research area provides challenges to scientific innovation and originality at
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the highest level with the ultimate goal of enhancing protective responses against
trypanosome infection.
Scientists working to produce a vaccine against Theileria sporozoites processed protein
materials for amino acid sequences in 1985 and screened DNA libraries to identify genes
coding for sporozoite antigens. In May, an international workshop on parasite antigens brought
together specialists in immunology and parasitology from around the world.
Studies on Theileria schizont-associated antigens have involved considerable basic research
on the bovine immune system, including the role of major histocompatibility antigens and their
interactions with parasite antigens at the surface of infected lymphocytes. T lymphocyte clones
have been established in culture, and these are being used to investigate several aspects of
cellular immunity.
However impressive these achievements may be, it is of continuing importance to ensure that
ILRAD's research programs retain their relevance to the real needs of African countries
affected by trypanosomiasis and theileriosis. In 1985, ILRAD provided support enabling
scientists from several African countries to participate in scientific meetings on
trypanotolerance, parasite antigens, control of ECF and other aspects of research on
protozoan diseases. The exchange of information and views in gatherings sponsored by
ILRAD has been invaluable in maintaining the focus of research efforts on the practical
aspects of disease control. The training program continued to expand in 1985 with additional
support for post-doctoral scientists from African countries who spend 6 to 9 months at ILRAD
expanding their knowledge and skills. Training and information activities will continue to
receive emphasis in future.
In concluding this brief foreword, I would like to emphasize the role of ILRAD's Board of
Directors, the scientific and supporting staff and the donor organizations and nations who
collectively support efforts to identify and introduce improved control measures for theileriosis
and animal trypanosomiasis. In 1985, Dr Leo Jenni of the Swiss Tropical Institute joined
ILRAD as a member of the Board of Directors and two senior scientists, Dr Max Murray and
Dr Tony Irvin, left to take up new positions after many productive years on ILRAD's research
staff. Another senior scientist, Dr Onesmo Ole MoiYoi, was appointed to the Council of
Kenyatta University by His Excellency Daniel Arap Moi, President of Kenya.
We acknowledge with gratitude the interest and financial support ILRAD receives for its
research and training activities from many countries and organizations. In 1985, ILRAD
continued to receive funds from the World Bank, UNDP, EEC and the Governments of
Australia, Belgium, Canada, France, Germany (FR), Italy, Japan, The Netherlands, Norway,
Sweden, Switzerland, the United Kingdom (UK) and the United States of America (USA). The
Government of Denmark added its support during the year, and the Rockefeller Foundation
pledged support beginning in 1986. In addition to funding for ILRAD's core programs, the
Governments of Belgium, France, Germany, Italy, Japan, The Netherlands and the UK
provided scientists through special project funds.
During the year, ILRAD was honoured to receive visits by Mrs M. Moriyama, Deputy Minister
of Foreign Affairs of the Government of Japan, Mr S. Husain, Chairman of the CGIAR, and
Their Excellencies the Ambassadors of Belgium, Japan, Norway, Switzerland and the United
States of America and the High Commissioners of Australia, Canada and the United Kingdom.
We value these visits, as well as contacts with scientific and technical advisors and
representatives of all the donor nations and organizations which support our work.
Finally, it is a pleasure to acknowledge the support ILRAD has received through the years
from the people and Government of Kenya. We look forward to the continuation of this warm
relationship with our Kenyan hosts.
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A.R. Gray
Director General
ILRAD
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Theileriosis
Theileriosis is a complex of tick-transmitted diseases caused by protozoan parasites of the
genus Theileria. The parasites infect wild and domestic animals—particularly cattle—and in
many parts of the world they are a major constraint to expansion and improvement of the
livestock industry.
The most important Theileria species are T parva, the causative agent of ECF affecting cattle
in East and Central Africa, and T annulata, the cause of tropical theileriosis in cattle in the
Mediterranean littoral and the Middle East, extending eastward to India, southern Russia and
the far east. Other important Theileria parasites include T sergenti, T orientalis and T mutans
in cattle and T hirci in sheep and goats.
Work at ILRAD concentrates on ECF, which occurs in Burundi, Kenya, Malawi, Mozambique,
Rwanda, Sudan, Tanzania, Zaire, Zambia and Zimbabwe. Altogether, some 25 million cattle
are at risk. At present, ECF is controlled principally by dipping or spraying cattle with
acaricides to kill the vector ticks, but this approach is becoming increasingly difficult and
expensive and alternative methods of control are urgently required. Recent advances in
chemotherapy have resulted in the development of a number of effective compounds for the
treatment of ECF, but prevention will always remain more desirable than treatment.
The prospects of immunizing cattle to prevent infection with ECF are promising, as cattle
which recover from ECF show a long-lasting immunity even in the absence of disease
challenge. However, different strains of T parva exist and immunization of cattle with one
strain will not necessarily protect them against challenge with an unrelated strain. The number
of strains found in cattle is unknown but certain isolates or combinations of isolates appear to
provide a broad protection. Thus, there are good prospects of controlling ECF by vaccination,
and ILRAD places particular emphasis on this approach.
The development of a vaccine requires knowledge of both the parasite and the host. Studies
of the parasite, initiated at the former East African Veterinary Research Organization, have led
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to a control strategy of immunizing cattle by infection with parasites and concurrent treatment.
Currently, this method offers the most practical and effective form of vaccination when
properly controlled, and it is being used in extended field trials in a number of countries. The
disadvantages are that infection with live parasites is potentially lethal if misused, full
protection may not be achieved in areas where several strains of the parasite are present, and
cattle may become carriers of the parasites used in immunization.
Work is in progress at ILRAD to overcome these disadvantages, but more emphasis is placed
on developing purified antigens for immunization which will not be subject to the problems
inherent in a live vaccine. The second major component of ILRAD's research effort is directed
towards identifying the mechanisms of host immunity to ECF. This work has involved
considerable basic research on the immune system of cattle. Details of work along all these
lines are given in the report which follows.
Lifecycle of the parasite
The Theileria parasite has a complex lifecycle in the bovine host and the vector tick. The
brown ear tick, Rhipicephalus appendiculatus, which transmits ECF feeds on cattle three times
—as a larva, a nymph and an adult. The parasites are transmitted most commonly when ticks
feed on infected cattle as nymphs and then on disease-free animals as adults.
Theileria sporozoites develop in the salivary glands of infected ticks and are passed to cattle
along with tick saliva when the ticks feed. In cattle, they attach to lymphocytes, white blood
cells of the immune system. Some sporozoites enter lymphocytes and develop into forms
called schizonts. Infected lymphocytes become enlarged cells called lymphoblasts that
multiply along with the parasites, resulting in a rapidly expanding population of parasitized
cells. The final stages of infection are characterized by large-scale destruction of cells and
often by death of the host.
During the course of infection, some of the Theileria schizonts differentiate into merozoites.
These are released from the lymphoid cells into the bloodstream and invade red blood cells
where they develop into forms called piroplasms. Ticks feeding on the host animal become
infected when they ingest red blood cells containing Theileria piroplasms. In the tick gut, the
parasites differentiate into gametes which fuse to form zygotes; these then develop into
kinetes in the cells lining the gut. The motile kinetes move through the gut wall into the body
cavity and migrate to the salivary gland where they enter the E cell of the type III acinus. Here
they form an elaborate intracellular sporoblast syncytium. Stimulated by tick feeding, the
sporoblast undergoes segmental fission and gives rise to 30,000 to 50,000 sporozoites. These
are introduced with tick saliva into a new mammalian host, initiating a new cycle of parasite
development.
The Sporozoite
Invasion of host cells
Studies at ILRAD have shown that Theileria sporozoites bind in vitro to a variety of bovine
target cells—including thymoeytes, both B and T lymphocytes and a small subset of
macrophages—but active infections are only established in lymphocytes. These studies have
been conducted with monoclonal antibodies which are used to identify cell types by
recognizing specific cell-surface antigens. Monoclonal antibodies are produced from hybrid
cells formed by the fusion of mouse spleen cells, primed to produce specific antibodies, and
mouse tumour cells capable of growing and multiplying in culture.
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A study initiated in 1984 compared in vitro sporozoite binding and infection of peripheral blood
mononuclear leucocytes taken from cattle and from African buffalo (Syncerus caffer). The goal
of this work is to elucidate the mechanisms which enable African buffalo to resist Theileria
infection. Sporozoites were used from two T parva subspecies: T p parva (Muguga) which
causes classical ECF in cattle and T p lawrencei which is carried asymptomatically by wild
buffalo but is highly pathogenic to cattle, usually causing fatal infections. There was no
significant difference in the number of target cells from cattle or buffalo which bound T p parva
or T p lawrencei sporozoites or became infected: about 30% of cells from both species bound
T p parva sporozoites, and about 20% developed schizonts after 1 week's exposure in vitro.
However, many fewer buffalo cells than cattle cells were transformed by T p parva infection
into a rapidly dividing state resulting in a continuously growing cell line. This limited
transformation of buffalo cells may explain the lower susceptibility of buffalo to T p parva
infection. Among cells infected with T p lawrencei, similar numbers of buffalo and cattle cells
were transformed into a dividing state. This suggests that buffalo possess other mechanisms
of resistance to T p lawrencei which enable them to remain carriers of infection without
suffering signs of disease: this resistance is not related to differences between buffalo and
cattle in the mechanisms of cell binding and the establishment of infection.
Sporozoites from different Theileria strains appear to bind to the same receptor molecule(s) on
host cells, suggesting that parasites bind host cells by a common mechanism. Experiments
were conducted in 1985 to elucidate this mechanism by identifying and isolating the
molecule(s) on the surface of bovine lymphocytes which serve as receptors for invading
sporozoites. The lymphocyte receptor was destroyed by treatment with proteinase K or
endoglycosidases, suggesting that the molecule is a glycoprotein (protein/carbohydrate
compound). Monoclonal antibodies raised against bovine peripheral blood leucocytes were
screened to identify antibodies which blocked sporozoite binding. One of the monoclonal
antibodies identified was shown to recognize three molecules on bovine leucocytes of
apparent molecular weights of 200,000, 135,000 and 50,000 daltons. Work is now in progress
to characterize these molecules more fully and also to identify the carbohydrates which are
linked to the proteins to form the receptor molecules. The goal is to find a way to block the
sporozoite entry process and thus protect cattle against infection with different Theileria
strains.
Monoclonal antibodies produced by bovine cells might recognize different antigens from those
recognized by mouse monoclonal antibodies and could extend present studies of the bovine
immune system considerably. A study was initiated in 1984 aimed at producing hybrid cells
from a fusion of antibody-secreting bovine B cells with mouse tumour cell lines, applying a
technique developed at the University of Alabama (USA) for human cells. Continuation of this
work in 1985 has failed to produce stable populations of murine × bovine hybrid cells, probably
because of loss of bovine chromosomes. As a result, efforts now concentrate on producing
hybrid cells from the fusion of bovine cells. Two continuously growing bovine leukaemia cell
lines are being investigated as possible partners for fusion with bovine antibody-producing
cells.
Immune responses against sporozoite antigens
Sera from cattle in ECF endemic areas have been shown to contain antibodies which
neutralize Theileria sporozoites thus potentially conferring protection against infection. The
sporozoite antigens recognized by antisera from immune cattle have molecular weights of
105,000, 67,000, 43,000 and 18,500 daltons. Several monoclonal antibodies have been raised
against T p parva sporozoites which prevent sporozoite entry into bovine lymphocytes in vitro.
One of these monoclonal antibodies recognizes a 68,000 dalton antigen. The antigen can be
fragmented into molecules of approximately 55,000 and 25,500 daltons which are also
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recognized by the monoclonal antibody. These sporozoite antigens might be capable of
stimulating protection if used in a vaccine against ECF.
Scientists are producing polyvalent antisera in rabbits to characterize the Theileria sporozoite
antigens in more detail. An antiserum produced against the 25,500-dalton molecule also
reacts with the antigens of 55,000 and 68,000 daltons. It is now being used to isolate the
68,000-dalton antigen. Biochemical investigations have revealed that this antigen is a
glycoprotein, though the carbohydrate moiety does not appear to play a role in inducing
protective antibody responses. Present efforts also focus on producing a polyvalent antiserum
in rabbits against the 105,000-dalton antigen recognized by sera from resistant cattle.
It has not yet been possible to produce sufficient antigenic material from Theileria sporozoites
for detailed chemical characterization or use in immunization trials. It has been recognized for
some time that a protective sporozoite antigen, once it is characterized, will have to be
produced by molecular biology techniques. Considerable work was earned out in 1985 to
identify T p parva gene sequences which code for protective sporozoite antigens and to
develop systems for the expression of these genes.
One type of expression library has proved useful in this work—a sheared genomic DNA library
using piroplasm DNA. This library has been screened with a variety of antisera and
monoclonal antibodies which recognize sporozoite antigens. The most successful experiments
have used antisera raised in rabbits. One rabbit antiserum which was raised by inoculating
rabbits with the purified 18,500-dalton sporozoite antigen blocks sporozoite infectivity in vitro.
Nine clones from the genomic library, recognized by this antiserum, are being screened to
confirm whether they represent part of the gene for the 18,500-dalton protein.
Genomic DNA will be screened further to obtain complete DNA sequences for the 55,000-,
25,500- and 18,500-dalton proteins. The next step will be to purify these proteins in large
quantities for use in experiments to block sporozoite entry in vitro, either by direct competition
or by using antisera raised against the proteins, and then for use in immunization experiments
in cattle. DNA libraries are also being screened with monoclonal antibodies and antisera from
resistant cattle in order to identify additional gene sequences coding for proteins which could
potentially stimulate immunity.
Because protection against sporozoite infection would be based on a humoral immune
response, studies were conducted in 1985 to identify the cells responsible for humoral immune
responses in cattle. The first step was to establish an in vitro culture system which would
demonstrate the antibody responses of bovine cells. Peripheral blood lymphocytes, spleen
cells and lymph node cells were taken from cattle and cultured in the presence of pokeweed
mitogen. Sheep red blood cells were added to the cultures to stimulate an immune response.
Several experiments were conducted with cells taken from many different animals, but results
were not encouraging: cell growth was strongly dependent on the mitogen, and few cells
developed to an antibody-producing state. When macrophages were depleted to less than 1 %
of the cultures, the proportion of cells producing antibody increased 2 or 3 fold. However, cell
growth was still dependent on the mitogen. Present work involves culturing cells from cattle
primed by subcutaneous injection of sheep red blood cells and boosting the cultures in vitro
with sheep red blood cells, but without the mitogen. The aim is to measure antibody production
and identify the different classes of antibody involved. The study will also focus on the
interactions between different subpopulations of bovine cells in the generation of humoral
immune responses.
The schizont-infected cell
Chapter1
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad85/chapter1.htm[5/19/2016 3:27:41 PM]
Proliferation of infected cells
The proliferation of bovine cells infected with Theileria schizonts is an important factor in the
lifecycle of the parasite and leads to severe pathogenic effects in the infected host. When cells
are transformed by certain strains of viruses into tumours, which also multiply rapidly, a class
of enzymes called protein kinases has been shown to play an important role. For this reason,
scientists at ILRAD have determined the levels of protein kinases in normal bovine cells and in
cells infected with Theileria schizonts.
Protein kinases change the molecular structure of proteins by attaching phosphates, a process
called phosphorylation. Such modifications of proteins play a role in cell growth and regulatory
events. There is evidence that phosphorylation may be involved in the proliferation of
Theileria-infected cells. Studies were initiated in 1985 comparing protein kinase activity in a
cloned, uninfected T-cell line and in the same cell line infected with T parva (Muguga). The
goal is to identify mechanisms specific to infected cells which might be modified to control the
disease.
During these experiments, the infected cell lines incorporated 90 times as much phosphate
into protein as the uninfected cells. Kinetic analyses showed that the infected cells were
larger, divided more rapidly and synthesized protein at least twice as fast as the uninfected
cells. Polyacrylamide gel electrophoresis has revealed at least five proteins, with molecular
weights ranging from 12,000 to 100,000 daltons, which are specifically modified by the
phosphorylation process. In order to establish that this pattern of phosphorylation is not a
peculiarity of one cloned cell line, uncloned cells infected with T parva (Muguga) and cloned
cells infected with T parva (Marikebuni) were shown to phosphorylate proteins as rapidly as
the original cell line used in the experiment.
Present investigations focus on whether the observed phosphorylation activity is due to the
activation of a specific enzyme in the host cell or to the presence of an enzyme of parasite
origin. The amino acids within the host cell which are targets for phosphorylation are also
being characterized, as well as the genes coding for kinases and other transforming activities.
Therleria-infected cloned bovine T lymphocytes have also been shown to produce a factor,
similar to T-cell growth factor, which can support the growth of uninfected bovine
T-lymohocyte clones dependent on the growth factor. This suggests that the autonomous
growth of Theileria-infected lymphocytes may be due to constitutive production of T-cell
growth factor or other hormone-like growth factors.
Antigenic changes on infected cells
ILRAD scientists have used monoclonal antibodies in efforts to distinguish antigenic markers
on the cell surface specific to Theileria-infected cells. The principal obstacle was thought to be
competition from immunodominant normal and activated host-cell antigens which prevent
recognition of weaker, Theileria-specific antigens. Work in 1985 concentrated on developing
techniques to block the production of antibodies to these other antigens and thus improve the
specificity of monoclonal antibodies against Theileria-infected cells. The most promising
approach involves injecting mice simultaneously with T parva -infected cells and with a strong
antiserum against uninfected blasting cells from the same animal.
Several experiments have revealed antigenic changes on bovine T cells associated with T
parva infection, though these antigens are also expressed by some noninfected lymphocytes.
Two monoclonal antibodies—J5 and J6—detect a T-lymphocyte antigen associated with cell
proliferation. T cells stimulated by the mitogen concanavalin A or by cell lines from other
animals express this antigen. It is also expressed on all cells infected by T parva, including
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what appear to be infected B cells. This implies that cells transformed by Theileria express an
antigen associated with proliferating T cells, regardless of their precursor origin.
Two other monoclonal antibodies, BT3/8.12 and J3, recognize a subpopulation of uninfected T
lymphocytes as well as all cells infected with T parva. Using recently developed techniques to
produce T-cell clones, it was possible to raise two distinct populations of uninfected T cells—
one with and one without the antigenic determinant recognized by BT3/8.12 and J3. A cloned
cell line that did not express the antigen was cultured in the presence of T parva sporozoites
and the percentage of cells with schizonts and with the antigen was monitored. It was shown
that the schizonts appeared first, while the antigen was detected after a delay of 2 days. The
antigen is not essential for cell multiplication; its real function is still unknown. Research
continues using monoclonal antibodies to define antigenic changes on the surface of
Theileria-infected lymphocytes. Changes are sought that are directly related to immune
responses which could protect the host against infection.
Immune responses against schizont-infected cells
Susceptible cattle undergoing acute infection with T parva produce cytolytic (cell-killing)
lymphocyte cells which are capable of killing their own infected and uninfected cells. These
killer cells are probably important in mediating the destruction of the immune system which is
a prominent feature of the disease. By contrast, cattle which have developed immunity against
ECF produce cytolytic lymphocytes which only kill cells infected with Theileria schizonts
(Figures 1 and 2). In this case, the killer cells recognize a parasite-induced antigen on the
surface of the parasitized cell.
Figure 1. Electron micrograph showing a cytolytic T lymphocyte (T) attached to the surface of
a parasitized lymphocyte (P). The arrow indicates the Theileria schizont in the parasitized cell.
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Figure 2. Electron micrograph showing the destruction of a parasitized lymphocyte (P) by a
cytolytic T lymphocyte (T). The arrow indicates a Theileria schizont in the parasitized cell.
Although a number of antigens have been identified on the surface of sporozoites which
stimulate immune responses both in vitro and in vivo, the antigenic changes which appear on
the surface of schizont-infected lymphocytes have not yet been fully defined. The mechanisms
involved in cell-mediated immunity are also complex, involving several cell types within the
immune system. In 1985, ILRAD scientists made considerable progress in the development of
in vitro systems and reagents which specifically recognize different cell types involved in the
immune response. The development of lymphocyte cloning techniques has also led to a better
understanding of the mechanisms of the immune response against cells infected with Theileria
schizonts.
Cytolytic cells belong to a particular subpopulation of T (thymus-derived) lymphocytes. An
important feature of T lymphocytes is that they react to foreign antigen presented on the
surface of other cells in connection with normal 'self ' molecules known as major
histocompatibility (MHC) antigens. Because the MHC molecules differ between individuals of a
species, T lymphocytes can only recognize foreign antigen on the surface of cells from the
same animal or an animal which shares the relevant MHC molecule. This phenomenon is
known as MHC restriction and T cells are often described as restricted by particular MHC
molecules. Because these MHC-restricted T cells are believed to be important in mediating
immunity against the schizont stage of Theileria parasites, ILRAD scientists have made a
major effort during the past 2 years to develop reagents for identifying T lymphocytes and for
defining different MHC molecules.
Definition of cell types
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Monoclonal antibodies have been produced at ILRAD which recognize the different types of
bovine leucocyte—cells involved in the immune response in cattle. These are T lymphocytes,
B lymphocytes, monocytes/macrophages and granulocytes. Studies in 1985 concentrated on
defining functionally important T lymphocyte subpopulations and populations, of
monocytes/macrophages. Once it becomes possible to identify bovine cell populations, their
role in responses to Theileria-infected cells can be ascertained.
Several monoclonal antibodies have also been derived which recognize bovine MHC antigens.
There are two main classes of MHC antigens: class I MHC antigens are expressed on most
cell types, whereas class II MHC antigens are expressed predominantly on cells of the
immune system. The important monoclonal antibodies identified at ILRAD in 1984 and 1985
are listed in Figure 3, along with their apparent specificities.
Cell Type
Monoclonal
antibody Specificity
Antigen
Designation
Molecular
weight
(K daltons)
T cells IL-A26 all T cells BoT2 55
IL-A27, IL-A28 all mature T cells BoT3 NI
IL-A11 IL-A12 T-cell subset restricted by
class-II MHC
BoT4 52, 55
IL-A17 T-cell subset restricted by
class-I MHC
BoT8 34, 35
Monocytes/
Granulocytes
IL-A22, IL-A24 monocytes/macrophages &
granulocytes
 NI
IL-A23 subpopulation of monocytes/
macrophages
 NI
IL-A25 pulmonary macrophages  NI
MHC molecules IL-A19 monomorphic determinant on
class-I molecules
 12, 44
IL-A1, IL-A4 polymorphic  12, 44
IL-A5, IL-A7 determinants   
IL-A8, IL-A9 on class-I molecules   
IL-A10, IL-A13    
IL-A21 monomorphic  26, 34
J11 determinant on class-II
molecules
 29, 31
NINot yet identified.
Figure 3. Monoclonal antibodies derived at ILRAD which recognize specific classes of bovine
leukocytes. Most of these antibodies were produced in 1984 and 1985.
Two of the monoclonal antibodies screened at ILRAD-IL-A26 and IL-A27—recognize all
mature T lymphocytes. The antibodies IL-A11 and IL-A12 identify a subpopulation of T
lymphocytes which recognize target cells that express antigenic changes in conjunction with
cla-ss II MHC antigens. Another antibody—IL-A17—identifies most T cells which recognize
target cells expressing antigenic changes in conjunction with class I MHC antigens (Figure 4).
Functional studies of the cell populations identified by these antibodies and biochemical
analyses of the target molecules they recognize suggest that they distinguish the two major
subsets of T cells in cattle, one subset involved predominantly in 'helping' the induction of
immune responses (recognized by IL-All and IL-A12) and the other the principal mediators of
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cell killing (recognized by IL-A 17).
Figure 4. Frozen sections of a normal bovine lymph node stained by the immunoperoxidase
technique with monoclonal antibodies that react with (A) all B lymphocytes, (B) all T
lymphocytes and (C) a subpopulation of T lymphocytes.
The T lymphocytes which mediate killing of Theileria-infected cells belong to the population
identified by the monoclonal antibody IL-A17 and, as expected, are restricted by class I MHC
molecules. Indeed the IL-A17 antibody has been shown to inhibit the cytolytic response of
some T lymphocytes, suggesting that the molecule recognized by IL-A17 has an important
function in the recognition or binding of the cytolytic lymphocyte to the parasitized cell.
The two subpopulations of cells recognized by the IL-A17 and IL-A12 monoclonal antibodies
can be infected with T parva sporozoites with identical frequency. Most Theileria-infected T
cell clones are recognized by either IL-A12 or IL-A17, indicating that the majority of
lymphocytes that become infected and transformed by the parasite arise from these two
populations.
Three monoclonal antibodies were also produced in 1985 which recognize bovine
monocytes/macrophages. They appear to recognize cells at different stages of maturation or
activation. Further studies are in progress to examine their functional properties.
Definition of MHC antigens
The genes which code for MHC antigens occupy a number of sites, called loci, along a bovine
chromosome. By comparison of a series of alloantisera in two international workshops, 17
class I MHC specificities have been identified which are believed to be encoded by genes at
one locus, called the BoLA (bovine lymphocyte antigen) A locus. ILRAD joined this
international effort in 1983 in a collaborative project initially supported by the British
Government's Overseas Development Administration (ODA) through the Agriculture and Food
Research Council's Animal Breeding Research Organization in Edinburgh.
Beginning in 1984, over 1000 Boran (Bos indicus) cattle in ILRAD's breeding herd have been
typed for class I MHC determinants using antisera and monoclonal antibodies. The objectives
are to compare the MHC antigens found in the Boran herd with those identified by the
international workshops, to select suitable animals for experimentation and to select breeding
groups with a view to producing offspring of particular MHC types. Five clearly defined
antigens have been detected which were not recognized by the international workshops.
These appear to be specific for B indicus cattle: they appear frequently among ILRAD's Boran
cattle but not at all among a sample of B taurus animals tested. As an important component of
this work, computer programs have been designed specifically for the analysis of bovine MHC
antigens. This aspect of the project is being conducted in collaboration with Strathclyde
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University (UK), and several other laboratories have expressed interest in using the programs
developed at ILRAD.
Particularly interesting class I antigens have been analysed using T-cell clones as well as
antisera and monoclonal antibodies. T-cell clones have also been raised which recognize
class II MHC antigens: this work represents an important advance because this technique
provides the best means now available to defile differences between individual cattle.
Bovine MHC antigens have been precipitated from cell lysates with antisera and monoclonal
antibodies and then analysed according to molecular weight and isoelectric point. Several
distinct class I molecules have been revealed. Studies initiated in 1984 have compared class I
MHC antigens from Theileria-infected and noninfected bovine cells, but as yet no biochemical
changes have been detected which are associated with Theileria infection.
In 1985, cytolytic T cells taken from nine cattle undergoing challenge with T parva were
screened on panels of parasitized cells with which they were matched or mismatched with
respect to six MHC antigens coded at the A locus. The cytolytic cells only killed target cells
with which they shared A locus antigens. Of the six antigens examined, three consistently
played a more important role in the induction of catalytic responses. These findings suggest
that parasite-induced changes on the surface of the host cell are either associated
preferentially with certain MHC molecules or may stimulate immunity more effectively when
associated with these molecules.
Cell-mediated immune responses
Bovine T lymphocytes infected with Theileria schizonts are readily maintained in a state of
proliferation in vitro. To study cell-mediated immune responses in cattle, in vitro techniques
have been developed to maintain populations of noninfected bovine T lymphocytes specifically
reactive against Theileria-infected cells. Cultures are initiated by adding T lymphocytes from
an immune animal to irradiated parasitized cells from the same animal in a mixed leucocyte
reaction. Irradiation of the parasitized cells (referred to as stimulator cells) prevents them from
proliferating, but the T lymphocytes (referred to as responder cells) are able to proliferate in
response to the antigens on the parasitized cells. Adding stimulator cells to the culture on
several occasions markedly increases the proportion of T lymphocytes reactive against the
parasitized stimulators. Individual T lymphocytes can then be cloned from these populations
by limiting dilution in the presence of appropriate growth factors. Repeated stimulation and
addition of growth factors maintains their proliferative slaws, thus producing cloned cell
populations. Cloned T-lymphocyte populations have also been produced for other purposes by
stimulating T lymphocytes repeatedly with the mitogen concanavalin A and maintaining the
proliferating cells with T-cell growth factor.
Two main types of T-lymphocyte clone have been identified which respond to
Theileria-infected cells:
1. Cells restricted by class I MHC antigens which kill parasitized target cells and are
specific for particular Theileria strains. These clones belong to the T-lymphocyte
subpopulation identified by the monoclonal antibody IL-A 17.
2. Cells restricted by class II MHC antigens which proliferate in response to
Theileria-infected target cells but are not cytolytic. These clones belong to the
T-lymphocyte subpopulation identified by the monoclonal antibody IL-A11.
The cloned, cytolytic T lymphocytes which are restricted by class I MHC molecules and are
specific for particular Theileria strains (1) are almost certainly analogous to the cells generated
in vivo in an immune animal. These clones have been used to examine the role of specific
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MHC antigens in the generation of an immune response as well as differences among parasite
strains. They have provided the first conclusive evidence that the catalytic T-lymphocyte
response may be parasite strain specific; this finding supports the idea that the antigen on the
surface of the parasitized cell is a parasite product.
The clones which proliferate in response to Theileria-infected cells but are not cytolytic (2) are
restricted by the class II MHC and are also parasite strain specific. These clones are being
used to study the rate of class II MHC antigens in the immune response to Theileria infection
as well as associated strain specificity. Their functional properties are also being investigated,
for instance their possible role as helpers to cytolytic cells or in the production of soluble
factors important in immunity.
The Theileria-specific, cytolytic T-lymphocyte clones are not only valuable reagents for
defining parasite strain heterogeneity, but also may be of use in identifying the
parasite-induced antigen(s) on the surface of the parasitized cell. Studies are in progress to
screen for the relevant antigens by monitoring the responses of Theileria-specific
T-lymphocyte clones to uninfected cells which have either been transfected with parasite
genes or incubated with antigenic subunits of the parasite.
Another study conducted in 1985 compared the cytolytic responses of cells taken from buffalo
with findings obtained from studies on bovine cells. Peripheral blood lymphocytes taken from a
buffalo showed a strong specific cytolytic response when cultured in vitro with cells from the
same animal infected with Theileria: up to 100 % of infected cells were killed, with
cytolytic-to-target-cell ratios as low as 7.5 to 1. However, this response was only observed
when lymphocytes were taken from a buffalo which had previously been infected with
Theileria. Cells taken from an uninfected buffalo did not show a cytolytic response to
autologous infected cells. Current work involves analysis of the cell populations and
mechanisms involved in resistance to Theileria infection in buffalo as well as comparisons with
findings obtained in cattle.
Epidemiology and experimental immunization
ECF epidemiology studies at ILRAD have concentrated on developing methods to distinguish
Theileria subspecies and strains. Early studies focused on serological screening using
antischizont monoclonal antibodies to characterize Theileria populations isolated from cattle
and from African buffalo. In 1985 efforts were also directed towards obtaining cloned parasite
stocks and DNA probes to characterize T parva strains.
ILRAD scientists are conducting ECF immunization trials in cooperation with the Kenya
Ministry of Agriculture and Livestock Development and the Agricultural Development
Corporation. Experimental immunization techniques are based on infection with live
sporozoites and simultaneous treatment with a long-lasting oxytetracycline antibiotic.
Strain characterization
To develop immunization procedures against ECF which will protect cattle effectively in the
field, scientists must be able to identify subspecies and strains of Theileria and determine
which strains of the parasite are crossprotective. Several approaches have been explored at
ILRAD for the precise characterization of parasite isolates. Large numbers of isolates have
been made from infected cattle and ticks in Kenya and other countries, and these have been
cryopreserved in the laboratory as stabilates of sporozoites or schizont-infected lymphoid
cells. Stocks have been characterized both in vitro and by crossimmunity testing in cattle.
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In vitro characterization has been based primarily on the recognition of schizont antigens by
specific monoclonal antibodies. It appeared originally that this type of serological screening
could be used to classify Theileria isolates into a limited number of antigenic groups or strains,
but by 1985, as more monoclonal antibodies were produced and more isolates tested, greater
antigenic diversity was detected. Although anti-schizont monoclonal antibodies have proven
useful for comparing Theileria isolates and selecting stocks for further characterization, it now
appears that monoclonal antibody responses alone are not sufficient to classify Theileria
isolates into groups of parasites which are crossprotective in vivo.
ILRAD scientists are now investigating the use of DNA probes to characterize Theileria
subspecies and strains. The first step has been to develop techniques for purifying Theileria
DNA. A simplified method is now being developed to produce highly purified DNA from
Theileria piroplasms. DNA has been extracted from blood infected with piroplasms of four T p
parva strains—Mariakani, Muguga, Kilifi and Marikebuni. Comparison of restriction enzyme
patterns shows a number of variations between the Muguga and the Mariakani strains.
Interestingly, the Muguga and Kilifi patterns show fewer variations, which is in agreement with
monoclonal antibody profiles and clinical studies showing crossprotection between these two
strains.
Two genomic expression libraries have been constructed from T p parva Muguga DNA and
one from DNA of T p parva Mariakani. These libraries carry complete gene sequences and
also fragments of regions between genes. Hybridization experiments are now being carried out
to identify sequences which hybridize differently in the two strains. These will be used to
identify both repetitive and single-copy gene sequences in the different genomes.
Several studies have suggested that Theileria antigenic diversity may be limited in field
situations where T p parva is maintained in a simple cattle/tick transmission cycle. However, in
places where cattle come into contact with African buffalo, the situation becomes much more
complex. T p lawrencei, the Theileria subspecies almost invariably carried by wild buffalo, is
characterized by low levels of schizont and piroplasm parasiaemia in cattle, but high mortality
rates. A collaborative study was initiated in 1984 to investigate the antigenic diversity of T p
lawrencei isolates and to improve available techniques for distinguishing this subspecies from
T p parva. Schizont-infected cell lines obtained from the Kenya Government's Veterinary
Research Laboratory and the Kenya Agricultural Research Institute were screened with 20
anti-schizont monoclonal antibodies raised against the two subspecies. By the end of 1985,
scientists had screened over 50 Theileria-infected buffalo cell lines and 50 bovine cell lines
which were either infected in vitro with sparozoites from ticks which had fed on buffalo or were
isolated from cattle exposed to buffalo.
Marked antigenic diversity was seen not only in isolates from different animals in the same
area, but also in different isolates taken from the same animal at weekly or monthly intervals.
One explanation for this striking antigenic diversity is the occurrence of mixed parasite
populations in isolates taken from buffalo. For example, after limiting dilution cloning, an
infected lymphoid cell line from one buffalo was shown to contain at least four antigenically
distinct Theileria populations. Once cloned, these populations retained their specific antigenic
profiles throughout an 8-month in vitro cultivation period.
Another possible explanation for observed antigenic diversity in T p lawrencei infections is that
these parasites may change antigenically during the course of infection in buffalo. To
investigate this possibility, a 2½-year study was conducted in collaboration with the Kenya
Government's Veterinary Research Laboratory, partially supported by the Government of the
Netherlands. This work was completed in 1985. A buffalo maintained under experimental
conditions was infected with a single stabilate of T p lawrencei and a steer was infected with
the stabilate at the same time. The steer developed severe clinical signs of T p lawrencei
infection and was treated with parvaquone (Clexon: Wellcome). The buffalo became a carrier.
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A schizont-infected cell line was isolated from the steer before treatment and tick and cell
culture isolates were made from the buffalo at regular intervals. Screening with a battery of
monoclonal antibodies revealed antigenic differences among cells isolated from the buffalo at
different times and between cells isolated from the buffalo and from the steer.
Due to the very small number of parasites seen in T p lawrencei infections, it is not possible to
obtain sufficient quantities of piroplasm DNA for genomic studies of this subspecies. However,
DNA has been prepared from schizont-infected buffalo sell lines, and these preparations will
be screened with genomic probes derived from T p parva piroplasm DNA. The goal is to
identify probes which will distinguish between the two Theileria subspecies.
The possibility of antigenic variation in T p lawrencei infection cannot be determined
conclusively until the existence of mixed infections can be ruled out. This could be done by
infecting Theileria-free cattle and buffalo with cloned parasites and checking for antigenic
diversity in sequential isolates taken over a period of time. Considerable effort at ILRAD now
concentrates on developing techniques to obtain Theileria clones derived unequivocally from
single parasites. Three approaches are being investigated. These involve the isolation of
sporozoites from a single infected tick acinus, the implantation of small numbers of Theileria
kinetes (the parasite form which develops in the tick gut and moves to the salivary gland) into
an uninfected tick, or the infection of bovine lymphocytes with small numbers of sporozoites
obtained by limiting dilution, followed by cloning the infected cell line.
Theileria infection rates are highly variable in ticks, making it difficult to identify ticks with only
one infected acinus. In a collaborative project conducted in 1985, scientists examined salivary
glands from ticks fed on an infected buffalo: salivary glands which contained only a single
infected acinus were crushed to extrude the T p lawrencei sporozoites into medium, and this
suspension was used to infect three Boran steers. Theileria schizonts were detected for a brief
period in two of the steers, but no piroplasms were observed. All three animals survived the
challenge and all showed anti-Theileria antibodies 4 weeks after infection. When the three
recovered steers and two susceptible controls were challenged with a T p lawrencei stabilate
prepared from ticks fed on the same infected buffalo, both controls and one recovered animal
died of typical T p lawrencei infection. The two steers which had demonstrated schizonts
following the initial challenge both recovered.
This experiment showed that it is possible to infect susceptible cattle with a direct inoculation
of sporazoites derived from a single tick acinus, although infections were transient. The fact
that one out of three steers was susceptible to homologous challenge could be due to
antigenic differences between the inoculated sporozoites derived from a single acinus and the
bulk stabilate. Another possibility is that the infective dose was insufficient to elicit a protective
immune response. This work was carried out in collaboration with the Kenya Agricultural
Research Institute and the Kenya Government's Veterinary Research Laboratory.
Another project carried out in 1985 aimed at establishing Theileria clones by transplanting
small numbers of kinetes into uninfected ticks. A mixture of haemolymph (equivalent to blood)
and gut content was taken from ticks infected with T p parva (Muguga), diluted and injected
into uninfected ticks. The number of kinetes contained in each inoculum was estimated by
analysis of the residual haemolymph/gut mixture, and recipient ticks were grouped according
to the estimated number of parasites received. After incubation, the recipient ticks were fed on
rabbits for 4 to 5 days, their salivary glands were dissected out and stained, and the number
of infected acini in each tick was determined.
The results showed considerable mortality among recipient ticks, no doubt due in part to the
crude nature of the inoculation. However, transplantation of 18 to 138 kinetes gave an
infection rate of 1 to 5 acini in a high percentage of surviving ticks. This kinete transplantation
technique could make it possible to obtain tick salivary gland acini with low Theileria infection
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rates more reliably than infection of ticks by natural feeding.
Efforts to obtain Theileria clones by limiting dilution have concentrated on techniques to infect
cloned bovine lymphoid cell lines with very small numbers of sporozoites. Sporozoites are
serially diluted and incubated with a fixed number of lymphocytes in the presence of T-cell
growth factor. After 4 days, the growth factor is removed and all noninfected cells die off. The
infected cells are then recloned. The aim is to produce cloned cell lines arising from a single
lymphocyte infected with a single sporozoite.
Experimental immunization
ILRAD scientists conducted an extensive field trial in 1985 at Kiswani, near the Kenya coast,
in collaboration with the Ministry of Agriculture and Livestock Development and the Agricultural
Development Corporation. The objective was to determine the effect of ECF immunization
combined with different acaricide treatment regimes on the productivity of beef cattle.
Eighty 2-year-old Boran steers were immunized by infection and treatment against ECF using
a local stock, T p parva (Marikebuni). Eighty similar nonimmunized cattle were used as
controls. All cattle were maintained in an ECF endemic area for 9 months, beginning in May
1985. They were divided into four groups of 20 immunized and 20 nonimmunized animals
under different tick-control regimes, as follows:
1. Forty cattle were sprayed with acaricides twice a week
2. Forty cattle were sprayed with acaricides once every 3 weeks
3. Forty cattle wore acaricidal ear tags
4. Forty cattle had no tick-control treatment.
All cattle were examined regularly: weights, tick counts and packed cell volumes (PCVs—an
indication of anaemia) were recorded weekly. Sera from all cattle were examined for
antibodies to T parva every month, and temperatures were taken every 2 days. Blood and
lymph node smears from all cattle with fever were examined daily, and most nonimmunized
cattle with ECF were treated with an antitheilerial drug. At the end of the 9-month trial period,
the treatment groups were compared in terms of the effectiveness of ECF immunization and
the different tick control regimes.
Eighteen of the 80 immunized cattle became infected with ECF. Of these, 15 recovered
spontaneously and 3 died: none were treated. Among the 80 nonimmunized animals, 58 cases
of ECF were recorded: 44 were treated with either parvaquone or halofuginone and 14 were
not treated. Fifteen died of ECF. Immunized cattle showed better weight gains than
nonimmunized controls under all four tick-control regimes. More detailed results are shown in
Figure 5.
Immunization and 
acaricide regime Number of cattle Number surviving
Mean weight gain of
survivors (kg)
Immunized
Sprayed twice/wk 20 20 67.6
Sprayed once/3 wks 20 19 51.2
Ear tags 20 19 62.4
No acaricide 20 19 55.6
Total or overall 80 77 59.2
Nonimmunized
Sprayed twice/wk 20 19 54.2
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Sprayed once/3 wks 20 15 38.8
Ear tags 20 16 34.2
No acaricide 20 14 41.1
Total or overall 80 64 42.1
Figure 5. Productivity in terms of survival and average weight gain of immunized and
nonimmunized Boran steers kept for 9 months in an ECF-endemic area at the Kenya coast
under different acaricide treatment regimes.
One constraint on the widespread implementation of ECF immunization by infection and
treatment has been the absence of a reliable in vitro assay to quantitate Theileria sporozoites.
At present, it is impossible to standardize the number of sporozoites inoculated during
immunization. It is also impossible to compare the infectivity or virulence of Theileria stocks
when observed differences may be due to unknown variations in sporozoite numbers.
A new method for counting Theileria sporozoites is being explored, using the monoclonal
antibody D, which recognizes sporozoites and sporablasts in different types of fixed and
unfixed preparations, but does not crossreact with any other developmental stage of the
parasite. The monoclonal antibody is labeled with fluorescein isothiocyanate and incubated
with the parasites, and the culture is analysed using ILRAD's fluorescence-activated cell sorter
(FACS). Three distinct populations appear which have been identified as sporozoite particles,
intact sporozoites and sporoblasts. Sporozoites sorted with the FACS maintain infectivity for
cattle and for bovine lymphocytes in vitro; they are about 0.8 µm in size.
Two T p parva stocks, Muguga and Marikebuni, have been analysed by this system. A
comparison of suspensions obtained from infected ticks which had fed for 4 days suggested
that the two stocks may have different maturation cycles: sporoblasts accounted for about
10% of suspensions from ticks infected with T p parva (Muguga), compared with 30 to 40% of
suspensions from ticks infected with the Marikebuni stock. Gene sequences which are being
identified in different Theileria populations may also provide useful tools for determining the
number of sporozoites present in parasite stabilates. The eventual aim of this work is to
produce Theileria stabilates which are well characterized in terms of number of sporozoites,
infectivity, monoclonal antibody and crossimmunity responses and sensitivity to
oxytetracycline.
Two types of drug strategy are commonly used in infection and treatment immunization:
oxytetracycline cover, usually at the time of infection, or parvaquone therapy 8 days after
infection. In situations where the two approaches are equally effective, oxytetracycline
treatment would be preferred because it is considerably cheaper and requires the animals to
be handled only once. However, some ECF infections are not contained by oxytetracycline
treatment.
Studies are in progress at ILRAD to elucidate the mechanisms of action of oxytetracycline.
The objective is to improve the effectiveness of this drug in infection and treatment
immunization and also to make it possible to anticipate situations where the drug may not be
effective. Oxytetracycline was added to bovine lymphocytes in vitro at various stages of
infection with T parva in concentrations similar to the level which could be expected in treated
animals. Results suggest that the drug affects the development of infected lymphocytes after
sporozoite attachment and entry. Enzyme studies indicate that oxytetracycline may affect
energy processes or the synthesis of proteins required for the establishment of the parasite in
the host cell. The drug appears to reduce the rate of establishment of infection rather than
inhibiting infection completely. Studies are now in progress to determine whether the observed
effects are due to direct action on the parasite, the host cell or both.
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Studies were initiated in 1985 to explore the immunogenic potential of a T parva stock isolated
in Zimbabwe, T p bovis (Boleni), which appears to cause mild reactions in cattle. When a
stabilate of the Boleni stock was inoculated into Boran cattle at ILRAD, all experimental
animals developed mild infections but recovered without treatment. These cattle then resisted
challenge with two virulent T p parva stocks, Muguga and Marikebuni.
A stabilate prepared from ticks which had fed on two of the experimental animals was
inoculated into 28 cattle. Most of these animals underwent mild reactions, though a few
reacted severely and one died. The survivors were divided into four groups and challenged
with stabilates of T p parva (Marikebuni), T p parva (Mariakani), T p lawrencei (Ngong) or T p
lawrencei (Buffalo 2306). Pairs of susceptible controls were also challenged with each of the
four stabilates. Most of the experimental cattle showed mild or inapparent reactions but those
infected with T p parva (Mariakani) reacted more severely. All the controls reacted severely,
and several died.
This experiment suggests that T p bovis (Boleni) generally causes mild reactions in B indicus
cattle and confers resistance to lethal challenge with some T p parva and T p lawrencei
stocks. Most attempts to grow the Boleni stock in culture have failed. It may be that this
parasite does not readily cause host cell transformation, making it difficult to establish infection
both in vitro and in vivo. This would account for the mild reactions observed in infected cattle.
Studies continue on T p bovis ( Boleni) in light of its potential value as a key immunizing stock.
While work continues on improving techniques for ECF immunization, several countries have
initiated field trials aimed at expanding immunization by infection and treatment. Long-term
studies are being conducted by national programs in Kenya, Rwanda, Zimbabwe and
Tanzania (Zanzibar), and by international programs operating in Burundi, Malawi and Zambia.
ILRAD is providing training and technical advice and support.
Two international workshops were held at ILRAD, in 1984 and 1985, to discuss the activities
and needs of national programs conducting ECF immunization field trials. In response to
requests made at these workshops, ILRAD is setting up a computerized database which can
be used by national programs to process and analyse data relating to the performance of
cattle immunized against ECF. Specific ILRAD support activities have been as follows:
1. Burund—characterization of local T parva isolates in vitro and in vivo, inservice training
2. Kenya—characterization of local T parva isolates in vitro and in vivo, assistance in
immunization trials (Ngong), inservice training
3. Malawi—characterization of local T parva isolates in vitro, provision of monoclonal
antibodies
4. Rwanda—characterization of local T parva isolates in vitro and in vivo, provision of
stabilates
5. Tanzania (Zanzibar)—consultancy and epidemiological survey, isolation and
characterization of local T parva stocks
6. Zambia—characterization of local T parva isolates in vitro
7. Zimbabwe—characterization of local T parva isolates in vitro and in vivo, assistance in
establishing theileriosis immunization program, inservice training.
Heartwater: some preliminary observations
Heartwater is a tickborne disease which causes serious illness and death in cattle, sheep and
goats. ECF immunization trials in Kenya's Coast Province have revealed a steady incidence of
this disease, and it is likely that the importance of heartwater will increase as more animals are
immunized against ECF. Heartwater is caused by the microorganism Cowdria ruminantium,
transmitted to livestock by the tick Amblyomma variegatum.
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Because of the potential importance of heartwater in ECF-endemic areas, ILRAD scientists are
looking at the development of the Cowdria organism in the tick vector and mammalian host.
One objective is to identify stages which could be used as a source of antigen for a diagnostic
test.
A stabilate of C ruminantium was derived from adult ticks originating at Kiswani in Kenya's
Coast Province. This stabilate is infective to susceptible cattle and sheep. Infected tick larvae,
nymphs and unfed adults have been examined by electron microscopy, as well as blood and
tissues from the brain heart, kidney, liver and spleen of fatally infected cattle.
No Cowdria was found in larval ticks, but Cowdria-type microorganisms were observed in
nymphs and unfed adult ticks in vacuoles within cells of the midgut (Figures 6 and 7). These
were observed from as early as 12 days up to 40 to 43 days after completion of feeding on an
infected cow. The gram-negative, bacteria-like microorganisms were of a generally similar
morphology, although slight variations in form and size were observed. Similar microorganisms
have not been observed in other tick organs, though this does not necessarily prove their
absence. Detection of the parasites will be greatly facilitated once a specific anti-Cowdria
antibody is available.
Figure 6. Electron micrograph of a section of a midgut epithelial cell taken from an adult
female Amblyomma variegatum tick. The tick had fed as a nymph on a cow infected with
Cowdria ruminantium and after moulting into an adult had attached to an uninfected animal.
The cell contains large lipid droplets and one vacuole containing microorganisms believed to
be C ruminantium. Another packed group of organisms in a round vacuole at the right edge of
the micrograph may be a different stage or form of the same parasite. The gut lumen is shown
at the top of the micrograph. Original magnification was 12,000.
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Figure 7. Electron micrograph of parasite believed to be Cowdria ruminantium within a large
vacuole of a tick midgut cell. The specimen was, fixed 35 days after the Ambiyomma
variegatum tick completed feeding on an infected animas. The parasites are bacillary or
cocco-baciliary in shape, about 0.5 to 0.75 µm in diameter and up to 2 µm long. Some profiles
show evidence of binary fission (arrows). Each parasite is enclosed by an outer and inner
limiting membrane typical of gram-negative bacteria. The cytoplasm contains fine DNA
filaments and particles resembling ribosomes. No internal membranes are present. Original
magnification was 35 000.
Immune responses and the tick
The brown ear tick, Rhipicephalus appendiculatus, which transmits ECF remains attached and
continues feeding on its bovine host for several days. During this period, the tick releases a
powerful anticoagulant into the host, along with attachment cement, a number of enzymes,
enzyme inhibitors and pharmacological agents. This 'cocktail' of biologically active molecules
is required to prime the attachment site, to allow tissue penetration, to assimilate the blood
meal and to block host defence mechanisms. However, there is evidence that some of these
substances are capable of stimulating a delayed-type hypersensitivity response in the host
which confers a degree of resistance to tick feeding.
When rabbits are sensitized by inoculation with tick salivary gland extract or by tick feeding,
they develop strong immunological responses to feeding ticks. This is shown by a reduction in
the number of ticks attaching to sensitized rabbits and by lower engorgement weights in the
ticks that do attach and feed. Similar immune responses are acquired naturally by cattle in the
field after multiple tick infestations. Researchers have tried to enhance this resistance by
immunizing cattle with tick antigens, generally using complex tick extracts. These procedures
have not improved upon the limited resistance attained naturally and they are probably also
impractical for field application. Research is in progress at ILRAD to identify specific
immunogenic substances in tick saliva and to explore the possibility of using high
concentrations of these substances in different adjuvant systems as a vaccine against ticks.
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Rabbits and guinea pigs which have developed immune responses to feeding ticks generate
antibodies that recognize a number of tick antigens. These antibodies have been used to
study the development of antigens during the course of tick feeding, indicating that the
presence and concentration of many tick salivary antigens vary in the course of the feeding
cycle. Larvae and nymphs also appear to lack many of the antigens present in adult ticks.
Because of the importance of anticoagulant activity for the survival of feeding ticks,
investigations in collaboration with the University of Nairobi's Department of Biochemistry
focused on purifying and analysing the anticoagulant molecule contained in tick salivary gland
extracts (Figure 8). This work was completed in 1985. The purified anticoagulant (Figure 9),
which is a prothrombinase complex inhibitor, does not stimulate an immune response in
rabbits, perhaps due to the extensive manipulation required for purification of the molecule or
to its rapid metabolism in the host. Thus, the anticoagulant is not a likely candidate to provide
the basis for a vaccine against tick infestation. However, studies on its structure may elucidate
underlying molecular mechanisms which could be manipulated to improve its immunogenicity.
Figure 8. The NPLC elution profile of an anticoagulant molecule purified from R
appendiculatus salivary gland homogenates. The chromatogram depicts retention times of
standard sizing proteins (arrows); protein absorbance at 210 nm. The tick anticoagulant
activity coelutes with a symmetrical protein peak with a retention time of about 20 minutes.
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Figure 9. A sodium dodecylsulphate polyacryiamide gel showing crude tick (R
appendiculatus) salivary gland homogenate (left lane) used as the starting material for the
purification of a tick salivary anticoagulant. The anticoagulant is shown in the right lane as a
single bard of purified protein
Other components of tick saliva are now being investigated with the aim of isolating individual
salivary components which might serve as antigens in a vaccine against ticks. Studies are in
progress to determine the role of different types of molecules in relation to enhancing tick
infestation and sporozoite transmission, circumventing host defences and mediating
inflammatory reactions. Antihistamines, enzyme inhibitors and immunosuppressive and
anticomplement molecules are being analysed.
In particular, scientists are looking for potentially immunogenic molecules which are present
during the initial stage of tick attachment. Analysis of tick salivary gland proteins by SDS
polyacrylamide gel electrophoresis (SDS-PAGE) indicates numerous changes during the
course of attachment and feeding. One dominant molecule of 67,000 daltons is absent in
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unfed ticks, evident soon after tick attachment and absent thereafter, suggesting that it may
be secreted or converted to other substances required for tick development as feeding
progresses. Anti-tick antibodies are now being used to purify this molecule.
Another antigenic protein, with a molecular weight of 90,000 daltons, has been isolated from
tick salivary glands. Localization of this protein within the salivary gland suggests that it may
contribute to the development of the water secretion mechanism during the process of tick
feeding. It might be possible to interfere with this important physiological process in the tick by
immunizing livestock with this antigen. This possibility is now being investigated.
Previous work at ILRAD has shown that when R appendiculatus ticks feed on an animal
immunized against ECF, anti-Theileria antibody present in the host is ingested by the ticks and
passes unchanged across the gut into the haemolymph. In 1985, scientists investigated
whether such antibody could interfere with the development of Theileria parasites within the
tick, thus interrupting the disease transmission cycle. Experiments wire based on a
monoclonal antibody (D,) raised against T parva sporozoites and on antisera from cattle
immunized against ECF.
The monoclonal antibody D1 neutralizes the infectivity of T parva sporozoites in vitro. Earlier
studies showed that it recognizes an antigenic determinant synthesized during sporozoite
development in the tick salivary gland 2 to 3 days after tick feeding commences. In the first
experiment conducted in 1985, a rabbit was injected daily for 4 days with 800 µl of D1 as
mouse ascites fluid, while a control rabbit was given injections of phosphate saline buffer.
Immediately after the first injections, 20 male and 20 female R appendiculatus ticks were
applied to the ears of each rabbit. These adult ticks had been infected as nymphs by feeding
on a calf infected with T p parva (Muguga). After 4 days' feeding, the partially engorged ticks
were removed and their salivary glands were dissected out and examined for parasites.
Haemolymph collected from the ticks was also examined.
About 0.006 µl of D1, could be detected in the haemalymph of the ticks fed on the
antibody-treated rabbit. There was a significantly lower percentage of mature sporozoites in
both male and female ticks fed on this rabbit, as compared to the percentage of sporozoites
reaching maturity in ticks fed on the control. This indicates that anti-Theileria antibody passed
across the tick gut during feeding, entered the haemolymph and affected the development of
parasites within the salivary gland.
In a second experiment, immunoglobulin (IgG2) was prepared from the sera of cattle which
were immunized against Theileria sporozoites and showed high anti-sporozoite antibody titres.
A rabbit was injected daily for 4 days with 500 µl of bovine IgG2 from an immunized cow and a
control rabbit was given injections of normal bovine IgG2. After the first injections, 20 male and
20 female R appendiculatus ticks infected with T p parva (Muguga) were applied to the ears of
each rabbit. Examination of their salivary glands after 4 days' feeding revealed fewer mature
sporozoites in ticks fed on the rabbit treated with immunized bovine IgG2 than in ticks fed on
the rabbis treated with IgG2 from nonimmunized cattle.
Evidence has already accumulated that cattle which recover from ECF produce antisporozoite
antibodies which may play a role in protecting them against subsequent infection. This work
suggests that anti-sporozoite antibodies might also suppress parasite development within the
tick.
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Trypanosomiasis
Trypanosomiasis is caused by protozoan parasites which infect cattle, sheep, goats, pigs,
horses, donkeys, camels, many types of wild animals and man. The most important
trypanosome species in economic terms are those which infect domestic ruminants in Africa:
Trypanosoma congolense, T vivax and T brucei brucei. Closely related T brucei subspecies
—T b rhodesiense and T b gambiense—cause human sleeping sickness.
Trypanosomes are most often transmitted cyclically by about 30 species and subspecies of
tsetse fly (Glossina spp). These insects infest a wide range of habitats over about 10 million
km2 of Africa, representing 37% of the continent or about half the habitable land. In regions
infested with tsetse flies, chronic trypanosomiasis causes a severe reduction in animal
productivity, reflected in poor growth, low milk yields, reduced capacity for work and infertility.
In severely infested areas, it is very difficult to keep livestock at all, and even human habitation
may be threatened.
Trypanosomiasis also occurs in Latin America, the Middle East and Asia. In these areas, the
parasites are transmitted mechanically by biting flies. Outbreaks of T vivax have been reported
in several South American countries, though the epidemiology of the disease has not been
fully documented. Another trypanosome species, T evansi, occurs in Africa, the Middle East,
Asia and South America. This mechanically-transmitted species causes a severe disease in
horses and camels and loss of productivity in cattle and domestic buffalo.
Programs to control trypanosomiasis have been in operation for nearly 100 years. Initial
Chapter2
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad85/chapter2.htm[5/19/2016 3:27:43 PM]
attempts involved control of the tsetse vector, either by destroying the wild animal populations
on which tsetse feed or clearing the bushy vegetation that tsetse require as breeding and
resting sites. More recently, most tsetse control programs have been based on the application
of insecticides. Considerable success has been achieved where control measures using
insecticide have been properly implemented—notably in Nigeria, Botswana, Zambia and
Zimbabwe. However, insecticide spraying is not entirely effective in areas of heavy tsetse
infestation, dense vegetation or high rainfall, and spraying programs require a substantial
investment and a high level of management. For these reasons, areas infested by tsetse flies
are expanding in many parts of Africa. There is also a risk that repeated, large-scale
insecticide spraying will have harmful effects on the environment.
Regular treatment with trypanocidal drugs has been an important control method since the
early 1920s. This approach has been successful in situations where livestock management
has been competent and consistent over time. Disease control regimes based on
chemotherapy must be implemented indefinitely because domestic animals are exposed to an
extensive reservoir of infection in the wildlife population. The possibility of drug resistance
developing in local parasite populations is also a serious consideration as no new trypanocidal
compound has been introduced for general use in the last 25 years.
The goal of ILRAD's research program is to develop improved measures to control
trypanosomiasis—measures which are effective, safe and economically sound. Research
activities are broadly based, but can be considered under three headings: improved control of
the parasites, enhanced host resistance to infection and trypanosomiasis epidemiology.
Improved control of the parasites
The three major salivarian trypanosome species proceed through several distinct stages
during their lifecycle in the tsetse vector and mammalian host. When a tsetse fly feeds on an
infected animal, it ingests trypanosomes along with blood, and these undergo a cycle of
development within the fly. T brucei develops in the tsetse midgut, proventriculus and salivary
gland, white T congolense develops in the midgut, proventriculus and mouth parts and T vivax
develops entirely in the mouth parts. All three species finish this phase of development as
metacyclic forms. When the infected fly next feeds, the metacyclic trypanosomes are injected
into the skin along with tsetse saliva.
When T congolense or T brucei parasites are transmitted to an uninfected animal by a tsetse
fly, a local skin reaction several centimetres in diameter—called a chancre—develops at the
site of the bite. The metacyclic trypanosomes develop further in the chancre, invade the local
lymph vessels and move through the regional lymph node into the bloodstream. T vivax
parasites also move from the skin through the lymphatic system to the bloodstream, but the
local skin reaction, if it occurs, is less severe.
Infection in the bloodstream is characterized by successive waves of parasitaemia as
trypanosome populations multiply rapidly, then most of the parasites die, but a few survive and
begin multiplying again. T vivax and T brucei parasites may also invade the connective
tissues, and, in later stages of infection, all three trypanosome species may be observed in the
central nervous system.
Metacyclic trypanosomes and the forms which develop in the mammalian bloodstream are
coated with a dense layer of antigen 12 to 15 nm thick. This surface coat is composed of
glycoproteins, referred to as variable surface glycoproteins or VSGs. Trypanosomes
developing in the tsetse fly are not coated with VSGs until they reach the metacyclic stage,
ready for transmission to a mammalian host.
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When an animal becomes infected, it produces antibodies against the VSGs displayed by the
first wave of invading trypanosomes. However, before all the parasites can be eliminated, new
trypanosomes emerge which are coated with different VSGs, and these are capable of
evading the animal's initial immune response. These trypanosomes multiply rapidly and the
host produces new antibodies, but then parasites appear with yet another VSG, always
keeping a step ahead of the host response. In laboratory animals, more than 100 different
VSGs have been observed amongst the descendents of a single trypanosome, and scientists
estimate that descendants of a single parasite could display several hundred different types of
surface coat.
This remarkable ability to change the antigenic composition of the surface coat—called
antigenic variation—is the primary mechanism which prevents most domestic animals from
developing effective immunity against trypanosomiasis. The same mechanism would enable
the parasite to evade a conventional vaccine, which works by priming an animal's antibody
responses against one or a small number of antigens.
Research at ILRAD concentrates on the mechanism of antigenic variation—its genetic basis
and the way VSGs are synthesized in the trypanosome and moved to the surface coat.
Studies also focus on different stages of the trypanosome lifecycle and the mechanisms
involved in the transition from one stage to the next. The goal is to identify factors which could
be manipulated to disrupt the development of the parasites or make them vulnerable to host
defences.
Antigenic variation: T brucei and T congolense
Trypanosomes contain a large number of VSG genes-probably several hundred. Each codes
for a different protein which can potentially form the protein component of the surface
glycprotein. Generally, only one of these genes is expressed at a time. Molecular biologists at
ILRAD and in other laboratories have been working to elucidate the mechanisms involved in
VSG gene expression and the genetic switching which takes place when trypanosomes
change from one surface coat to another.
To be expressed, a VSG gene must be located in an expression site near one end of a
chromosome, called a telomeric site. From this site, the gene is transcribed from DNA into
mRNA, and from mRNA it is translated into the protein of the surface coat. There are several
expression sites in the trypanosome genome, but a gene is transcribed into mRNA from only
one site at a time. Antigenic switching may occur when VSG genes are exchanged in an
active expression site or when a different expression site becomes activated. The mechanism
involved in the activation of a VSG-gene expression site remains unknown.
Antigenic switching also occurs when one gene replaces another in an active expression site.
The most thoroughly studied situation occurs when a VSG gene is replaced in an expression
site by a duplicated copy of another VSG gene. Gene replacement most commonly involves
recombination between repetitive sequences within a 'barren' region on one side of the VSG
gene in its expression site. ILRAD scientists have been analysing this flanking region to see if
it might also be involved in the mechanism of gene switching without gene replacement.
These studies have concentrated on the region surrounding two copies of the T brucei ILTat
1.3 VSG gene, one expressed and one not expressed. Both gene copies are located in
telomeric sites-one on a minichromosome and one in an expression site. The 5' barren region
of the gene copy in the expression site was sequenced in 1985 and was found to be identical
whether the site was active or not, suggesting that DNA sequence alteration in the barren
region does not have a necessary role in the regulation of activity of this site. Comparison with
the 5' flanking sequence of the minichromosome gene copy suggested that the two gene
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copies were not derived independently from a nontelomeric gene, but rather derived one from
another by serial duplications. This would imply that trypanosome VSG genes may move from
one telomeric site to another by a mechanism similar to that involved in movement from a
nontelomeric to a telomeric site.
A segment of DNA from an expression site formerly occupied by the ILTat 1.3 gene was also
cloned from a trypanosome in which the expressed copy of the gene had been lost.
Transcription studies indicated that the loss of the ILTat 1.3 gene was the result of
replacement by another VSG gene in the expression site. Experiments using orthogonal
field-alternation gel electrophoresis (OFAGE) showed that the new DNA segment came from a
minichromosome. Sequence analysis showed that at least 16 barren region repeats were
brought into the expression site from the minichromosome along with the new VSG gene. This
indicates that minichromosome VSG genes may be flanked by extended repeat arrays like
those flanking expressed genes, in contrast to the short arrays next to nontelomeric genes.
These observations also suggest that VSG genes associated with relatively long flanking
arrays may be more likely than other genes to move into expression sites.
This work showed that the ILTat 1.3 VSG gene remained on the same small chromosome
whether it was expressed or not. In conjunction with mapping data, this observation provides
evidence that VSG gene expression switches may not always involve chromosome
rearrangements. On the other hand, translocations and deletions of large segments of
chromosomes can lead to alteration of VSG gene expression. Using OFAGE, scientists
observed an expressed T brucei ILTat l. l VSG gene at the end of a chromosome which was
later lost by a large deletion.
Relatively little work has been published on the molecular biology of antigenic variation in T
congolense. In collaboration with the Vrije Universiteit Brussel (Belgium), ILRAD scientists are
investigating whether the mechanisms underlying antigenic variation in T congolense are
comparable to those observed in other trypanosomes. Cloned T congolense VSG genes have
also been used as hybridization probes to determine their usefulness in studies of the
epidemiology of trypanosomiasis.
Figure 10. Interchromosomal duplicative translocation of the T congolense IL-Nat 2.1 VSG
gene. Chromosome-sized DNA molecules from six ILNaR 2 trypanosome clones; expressing
(lanes 1-3) or not expressing (lanes 4-6) IL-Nat 2.1 VSG, were resolved in a 1.5% agarose gel
by OFAGE at 20-second pulse intervals. A. Photograph of Ethidium bromide (EtdBr)-stained
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gel. The chromosomesized DNA in the gel was transferred to nitrocellulose filter paper and
hybridized with pcN68 a recombinant plasmid containing sequences encoding ILNat 2.1 VSG.
B. Autoradiograph of this filter. Approximate sizes of chromosomes estimated by comparison
with those of T brucei are indicated.
Detailed investigations have concentrated on two VSG genes, each from antigenically distinct
T congolense populations representing different serodemes. Trypanosome clones from the
ILNaR 2 repertoire retained a basic copy of the ILNat 2.1 VSG gene on a minichromosome
with an average size of 100 kb, whether the gene was expressed or not. Clones which
expressed the ILNat 2.1 gene were found to have an extra copy of the gene located on a 700
kb chromosome, but the extra copy was not present in clones which had switched off
expression of the gene. No alteration in the molecular karyotypes of the ILNaR 2 clones was
observed: the number and size of chromosomes between 200 and 1000 kb appeared constant
among all the variants examined (Figure 10). These observations indicate that the ILNat 2.1
VSG gene is expressed by duplicative transposition. They also suggest that rearrangement of
the ILNat 2.1 gene is not associated with large-scale chromosome translocations.
By contrast, trypanosome clones in the T congolense ILNaR 3 repertoire showed the same
number of copies of the ILNat 3.2 VSG gene whether the gene was expressed or not. This
VSG gene was not found in the genomes of T congolense clones from other serodemes. No
signals of hybridization were detected, either in restriction enzyme digests of total DNA or on
whole chromosomes separated by OFAGE (Figure 11). This observation extends results from
similar investigations using the ILNat 2.1 VSG gene in 1984. The sequences encoding these
two T congolense VSGs occur only in parasites of the two respective serodemes. If
sequences encoding other T congolense VSGs are also present only in their respective
serodemes, then, as hybridization probes, they might be a useful adjunct for serodeme
characterization.
Chapter2
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad85/chapter2.htm[5/19/2016 3:27:43 PM]
Figure 11. T congolense ILNat 3.2 VSG cDNA sequences are absent from heterologous
genomes. A. DNA (2 µg) from T congolense clones from eight different serodemes was
digested with Mbol, size-fractionated in a 0.8% agarose gel, blotted and hybridized with ILNat
3.2 VSG cDNA. Lanes contain DNA from clones as follows: (1) ILNat 3.1, Serengeti, Tanzania;
(2) ILNat 2.1, Transmara, Kenya: (3) 776, Kigoma, Tanzania; (4) ILNaR 1, Nairobi, Kenya; (5)
C1, Busoga, Uganda; (6) C47, Kigoma, Tanzania; (7) C36, Ikoma, Tanzania; (8) ILNat 5.1,
Kilifi, Kenya. DNA fragment sizes are given in kb. B. Chromosome-sized DNA molecules from
trypanosome clones belonging to three distinct serodemes were fractionated by OFAGE in a
1.5% agarose gel for 8 hours at 20-second pulse intervals, stained with EtdBr and
photographed. C. DNA in the gel shown in panel B was transferred to a sheet of nitrocellulose
filter and hybridized with ILNat 3.2 VSG cDNA. An autoradiograph of the hybridization is
shown. White arrow in panel B points to the medium-sized chromosomes of the ILNaR 3
clones with which the ILNat 3.2 VSG cDNA hybridizes. Lanes contain chromosome-sized DNA
molecules from trypanosome clones as follows: (1) ILNat 3.1. (2) ILNat 3 3, (3) ILNat 3.2, (4)
ILNaR 1, (5) 776. (6) ILNat 2.1.
Antigenic variation: T vivax
Electron microscopic studies in 1984 revealed a surface glycoprotein coat on metacyclic forms
of both East and West African stocks of T vivax, similar to the surface coat on T brucei and T
congolense. Studies on T vivax VSGs in 1985 concentrated on extending the antigenic
analysis of the ILDaR 1 serodeme from West Africa. Work was hampered by the very small
numbers of T vivax parasites available for study and by the apparent instability of VSGs
displayed by this species. However, employing a recently developed culture system, new
antigenic types were generated not previously recognized in early bloodstream populations in
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goats and mice. Since the culture system apparently mimics the lifecycle of the parasite in the
tsetse vector, it will be of interest to compare the new antigenic variants produced in culture
with the antigenic types displayed by metacyclic trypanosomes from tsetse.
Serodeme relationships were established in T brucei and T congolense infections by
examining the resistance of animals to homologous or heterologous challenge following a
regimen of cyclical infection and treatment. However, this was not always possible with T
vivax. A detailed investigation in goats employing stocks and clones from East and West
Africa showed that homologous immunity is difficult to elicit, sometimes even after several
challenges by infected tsetse. This was principally ascribed to the very low number of
metacyclic trypanosomes extruded by T vivax-infected tsetse and to the antigenic lability of
the bloodstream trypanosomes, as demonstrated in earlier studies. However, in further
experiments, it was possible to demonstrate immunity in cattle to homologous tsetse challenge
when the animals were allowed to recover for several months following self-cure of the
primary infection. In some instances, protection against heterologous challenge was also
elicited, using stocks of T vivax from different areas of Kenya. This suggests that immunity to
T vivax infection may entail responses to the entire antigenic repertoire of a serodeme.
A relatively stable bloodstream variant-ILDat 1.2—was identified, and work is in progress in
collaboration with the University of Victoria (Canada) to characterize the ILDat 1.2 VSG with
respect to molecular weight, amino acid composition and the presence of a cross-reactive
determinant/fatty acid tail. This VSG will also be compared to VSGs from other trypanosome
species.
The Trypanosome lifecycle: stage-specific proteins
Trypanosomes develop in the mammalian bloodstream from rapidly dividing to nondividing
forms. In T brucei, the rapidly dividing bloodstream stage is associated with a long-slender
shape, while the nondividing form has a short-stumpy appearance. Parasite transition to
nondividing forms helps to limit the severity of infection and is also thought to prepare the
trypanosomes for transmission to tsetse. Once the parasites enter the fly, they lose their VSG
coat and develop into procyclic forms in the tsetse midgut. A full understanding of the
mechanisms involved in these transitions may suggest specific ways to disrupt parasite
development. Interventions which hasten the change to nondividing or uncoated forms would
limit the growth of trypanosome populations and make the parasite vulnerable to the host's
immune system.
Unique proteins synthesized at different stages of the trypanosome lifecycle present possible
targets for chemotherapeutic or immune attack. Protein profiles of rapidly dividing and
nondividing bloodstream forms and uncoated procyclic forms of T brucei are being compared
using two-dimensional gels. Proteins are also being identified which may be specific to
particular species or subspecies and could be used for epidemiological or diagnostic
purposes.
Several stage-specific proteins have been observed. The most obvious are the VSGs which
are present on both bloodstream forms but absent on procyclics. Among other proteins noted,
several were present in only one of the three stages, some were present only in the two
bloodstream forms and others were present only in nondividing bloodstream and procyclic
forms.
A collaborative study with the University of Massachusetts/Amherst (USA) has focused on
some nonvariant antigens specific to bloodstream forms of T brucei and T congolense. These
antigens were shown to be proteins, and antibodies generated against them in rabbits were of
the IgG class. Electron microscopic studies suggested that some of these nonvariant antigens
may be located on the surface of the parasites, making them possible candidates for
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immunization studies. These antigens will be analyzed in more detail and then tested for their
potential protective capacity.
Analysis of microsomal and putative Golgi fractions and high-speed supernatants of ruptured
trypanosomes using SDS-PAGE showed that rapidly dividing bloodstream parasites lack a
number of proteins which are prominent in nondividing bloodstream forms. Present
investigation of developmental changes in T brucei includes the preparation of antisera against
these stage-specific proteins. Histories, which are nuclear proteins involved in the expression
of different genes, were taken from highly purified trypanosome nuclei and analysed in 1985.
Differences were noted among histones from rapidly dividing and nondividing bloodstream
forms and procyclic forms.
Research was initiated in 1985, in collaboration with the Vrije Universiteit Brussel (Belgium), to
detect differences in trypanosome gene expression associated with specific stages of the
parasite lifecycle. This work has concentrated on dividing and nondividing bloodstream forms
of T brucei and on bloodstream and metacyclic forms of T congolense. The method consists
of preparing cDNA from mRNA of one stage, hybridizing it to excess mRNA from another
stage and selecting nonhybridized material which should be enriched for stage-specific
transcripts. Preliminary studies have shown that this technique should be useful in identifying
transcripts specific for T brucei nondividing forms.
Aspects of Trypanosome metabolism
Studies on trypanosome metabolism have as their ultimate goal the identification of avenues
for blocking parasite growth. These studies may also lead to a better understanding of the
pathogenic effects of trypanosomes on their hosts, thereby suggesting approaches for
preventing or alleviating the most serious results of infection.
Trypanosomes ingest biologically important molecules from the host internal environment,
such as nutrients and differentiation signals, through a process of endocytosis by coated
vesicles (Figure 12). To study the host bloodstream molecules required for parasite
development, coated vesicles from bloodstream forms of T brucei were purified and
characterized. Electron microscopic examination revealed a difference between T brucei
coated vesicles and similar endocytotic vesicles from other nucleated cells: in addition to an
external coat of clathrin, the trypanosome vesicles have an internal coat of electron-dense
material, presumably enclosed amounts of surface VSG. Antisera tested so far have detected
host IgG and IgM immunoglobulins and serum albumin in trypanosome coated vesicles.
Immunological analysis conducted in collaboration with Yale University (USA) indicated that
clathrin derived from trypanosomes differs anti-genically from mammalian clathrin.
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Figure 12. Coated vesicle endocytosis in T brucei. The arrows indicate coated vesicles near
the flagellar pocket of a trypanosome. Original magnification was 100,000 (S. Ito).
In the tsetse vector, T vivax parasites develop entirely within the proboscis. An interesting
phenomenon associated with T vivax cultivation in vitro is the attachment of last-stage
bloodstream forms to Matrix Gel Green A beads. Work in 1984 indicated that attachment is
based on a receptor-ligand mechanism between the parasites and the Green A dye on the
surface of the beads. Ultrastructural studies in 1985 confirmed that T vivax attachment to
beads in vitro closely resembles parasite attachment to the proboscis of infected tsetse.
Biochemical studies have involved modifying the Green A dye beads or exposing the parasites
to a variety of different but structurally related dyes bound to the beads. These studies have
shown that the receptor-ligand interaction responsible for binding to the dye is specific for a
certain molecular structure. The binding process is energy dependent and membrane
mediated: binding is inhibited at 4°C, but resumes when cultures are returned to 27°C. So far
attempts to generate an antibody to the Green A dye have been inconclusive. Isolation of
either the T vivax or tsetse molecules involved in the binding process might provide a novel
method of intervention leading to improved disease control.
An awareness of the important protective role played by the trypanosome VSG has led to
interest in the mechanisms of attachment and release of the parasite's surface coat. The VSG
appears to be anchored in the parasite membrane by a hydrophobic lipid moiety at its
C-terminus. When trypanosomes are disrupted in vitro, VSG molecules are released from
fragments of plasma membrane by enzymatic cleavage of the lipid residue. If trypanosomes in
the mammalian bloodstream shed their surface coat by a similar mechanism, then
pharmacological stimulation of the lipase responsible for cleavage might be developed into a
new drug therapy. Preliminary studies at ILRAD suggest that T brucei parasites do shed their
surface coat by enzymatic cleavage in vivo, both as bloodstream forms and during transition to
the uncoated procyclic stage.
In order to identify the sites of important metabolic functions in trypanosomes, biochemical
and electron microscopy techniques have been developed for isolating and identifying
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subcellular fractions of the parasites. Earlier studies on the process of VSG synthesis included
the purification of rough and smooth endoplasmic reticulum and Golgi fractions. In 1985,
highly purified fractions of trypanosome flagella, lysosomes and glycosomes were obtained
(Figure 13). In addition to research on VSG formation, these fractions have been used to study
trypanosome proteoiytic (protein-splitting) enzymes.
Figure 13. Flagella (A). primary lysosomes (B) and glycosomes (C) isolated from T brucei
MITat 1.2 by density gradient centrifugation in Percoll.
Studies focusing on bloodstream forms of T brucei and T congolense have demonstrated the
presence in parasite lysosomes of a family of thiol-dependent proteolytic enzymes sharing
similar biochemical properties. Biochemical studies have shown that they are similar to
mammalian lysosomal thiol proteases such as cathepsins B or L. Other non-thiol-dependent
proteases have also been observed, indicating that trypanosomes contain at least two classes
of proteolytic activity. Antibodies are now being prepared against these enzymes to confirm
their location within the parasite and to ascertain whether they are released into the host
bloodstream. Research is also in progress to identify parasite and host factors which may
control their activity.
Trypanosome cultivation in vitro
The in vitro cultivation of trypanosomes was one of 1LRAD's first major achievements. By the
end of 1983, culture systems were established which support the development of all three
major African trypanosome species throughout their lifecycles. Work in this area in 1985
concentrated on simplifying and standardizing culture systems to produce large numbers of
parasites at the metacyclic stage of development.
Two culture systems were developed in 1984 to propagate metacyclic forms of T vivax. Large
numbers of metacyclic forms of five T vivax stocks can now be harvested on a regular basis.
Observations on the in vitro development of metacyclic forms of this species have suggested
that they may pass through two morphologically distinct stages of development. Present work
includes further investigation of this possibility as well as in vitro cultivation of additional T
vivax stocks, particularly stocks newly isolated in the field.
Metacyclic forms of three T congolense stocks were cultivated initially in 1983. In 1985, a
fourth stock of T congolens—Trans Mara—was cultivated successfully; large numbers of
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metacyclic forms of this stock can now be produced.
Although T brucei was the first trypanosome species to be maintained in culture throughout its
lifecycle, efforts to produce metacyclic forms of this species in large numbers have not yet
been successful. Work continued in this area in 1985. Bloodstream forms of T b brucei
(TC221) taken from infected mice were maintained in vitro and the culture system was
manipulated to produce forms which resembled metacyclic parasites and were infective to
mice. However, it is not yet possible to produce large numbers of these metacyclic-like
parasites on a continuous basis.
Improved host responses
Early studies on T brucei infections in cattle, eland and African buffalo showed that two
responses are involved in host control of parasitaemia in the bloodstream-control of parasite
growth by nonimmunological processes and destruction of parasites by host antibodies.
Subsequent work in resistant and susceptible strains of mice has indicated that T brucei
parasites require host-derived growth factors in order to multiply: these factors are responsible
for maintaining the parasites in the rapidly dividing (long-slender) stage and inhibiting or
preventing their transition to the nondividing (short-stumpy) stage. Host antibody responses
capable of destroying trypanosomes are induced by degenerating stumpy-form parasites:
these responses are specific for exposed or external epitopes on parasite VSG molecules and
are depressed in some infected animals.
Studies have been undertaken to identify the host-derived growth factors required for the
maintenance of trypanosome populations. Bovine serum components which stimulate
trypanosome multiplication in a feeder layer-dependent culture system are of a molecular
mass greater than 100,000 daltons. The molecules are not lipids, lipoproteins or
immunoglobulins and appear to be of a similar size range in sera from mice, rats, goats and
cattle. This area of investigation did not progress substantially during 1985. However, new
culture systems have been developed at the University of Bordeaux (France) which permit the
cultivation of bloodstream forms of T brucei without feeder layer cells. The introduction of
these techniques at ILRAD provides hope that T brucei growth-factor requirements can be
investigated more thoroughly in coming years.
The growth rate of T brucei parasites in mice can be modified by treatment of the host with
dead Corynebacterium parvum, a bacterium which acts as a nonspecific immunostimulator. In
treated mice, parasitaemia is reduced by more than 200 fold, though the effect is short lived.
This effect appears to result from an acceleration in the rate of transition from dividing to
nondividing parasite forms. The effect is greatest in normal mice, but is also detected in mice
irradiated either before or after C parvum treatment. Radiolabeling of C parvum organisms
indicates that they are located predominantly in phagocytic cells of the liver and lungs of
treated mice, but they can also be detected for a few days in the spleen. Serum or spleen
cells from treated mice have no detectable effect on parasites during short-term (3 h)
cultivation in vitro and do not increase resistance when transferred to untreated animals.
These results suggest that C parvum treatment might inhibit the production of host-derived
factors which promote the growth of T brucei, although blocking factors cannot be excluded.
Clarification of how C parvum treatment works to accelerate parasite differentiation could shed
light on the regulation of parasite populations in resistant breeds of cattle and wild animals.
However, full elucidation of the effects of C parvum treatment awaits the identification of
trypanosome growth factors. Present studies also aim to determine which host cells and which
components of the C parvum organisms are involved in control of trypanosomes.
Some strains of mice, notably C3H/He, are highly susceptible to trypanosomiasis. They do not
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produce detectable antibodies against the parasites although their antibody-producing B
lymphocytes are extensively activated during infection. ILRAD scientists measured
B-lymphocyte activation in susceptible mice infected with T brucei by assessing the
incorporation of 125I-iododeoxyuridine as an indication of DNA synthesis. Maturation of the
B-lymphocyte response was measured by assessing the presence of immunoglobulin in the
cytoplasm of the cells. By the time of peak parasitaemia, approximately 10 to 18% of spleen
cells in infected susceptible mice contained immunoglobulin, a proportion of which could bind
to the VSG of the infecting trypanosomes, yet no parasite-specific antibodies were detected in
their sera. These findings suggest that parasite-specific B lymphocytes are suppressed at a
terminal stage of maturation.
This possibility was examined by in vivo and in vitro biosynthetic labeling with L-35-S-
methionine, a radioactive amino acid which is incorporated into newly synthesized proteins,
including immunoglobulins. It was found that immunoglobulin secretion by
immunoglobulin-containing cells was severely impaired in susceptible mice infected with T
brucei. A similar phenomenon was observed in susceptible mice infected with T vivax.
This block in lymphocyte function in susceptible mice infected with T brucei or T vivax can be
relieved by elimination of the trypanosomes. Antibody was detected in the bloodstream within
20 hours of parasite removal by treatment with diminazene aceturate (Berenil: Hoechst), which
suggests that the block in antibody secretion was maintained by the presence of living
trypanosomes or short-lived components of dying parasites.
To investigate the link between trypanosome infection and the suppression of B-lymphocyte
development, scientists went on in 1985 to investigate the influence of T brucei infection on
the capacity of mice to produce antibody against other types of antigens which do not
crossreact with trypanosomes. Rabbit red blood cells triggered strong immune responses in
noninfected mice, but infected mice rapidly lost the capacity to mount immune responses
against this antigen. The immunosuppressive effect was relieved within 24 hours of parasite
elimination by treatment with diminazene aceturate (Figure 14). Thus parasite-induced
suppression of the immune response against rabbit red blood cells appeared to be similar to
regulation of the response against the parasites themselves.
Number of mice
Day 0
T brucei
infection
Day 4
Rabbit red blood
cells
Day 7
Diminazene
aceturate
Day 8
Ab-forming cells/
500,000 spleen 
cells (± 1 SD)
10 - + - 186 ± 18
10 - + + 164 ± 24
10 + + - 21 ± 6
10 + + + 149 ± 16
10 + - - 2 ± 1
10 + - + 2 ± 2
Figure 14. Influence of T brucei (GUTat 3.1) infection on the stimulation of antibody-forming
cells against rabbit red blood cells in a susceptible strain (C3H/He) of mice. Six groups of 10
mice each were subjected to different treatment regimes. Parasites were detected in the blood
far 24 hours after treatment with diminazene aceturate, and were cleared between 24 and 48
hours after treatment.
Experiments were conducted to examine the influence of the introduction of trypanosomes into
mice already producing antibody against rabbit red blood cells. Groups of mice were injected
with rabbit red blood cells and also with trypanosomes on the same day or 1, 2 or 3 days later.
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The parasites had no influence on antibody response to the rabbit cells, as measured on the
fourth day. Similarly, when mouse cells secreting antibody against rabbit red blood cells were
incubated with serum from infected mice for up to 3 hours in vitro, antibody secretion was not
inactivated. These results indicate that the presence of parasites per se does not inactivate
antibody-secreting cells. The parasite-induced response which prevents the final maturation of
antibody-secreting cells requires some days to be activated and is dependent on the
continuous presence of the parasites.
Trypanosome infection is associated with disruption of the spleen, the organ in which
antibody-secreting cells are produced. Studies conducted in 1985 showed that T vivax
infection causes severe pathology in the spleen of susceptible, but not resistant mice. Within 9
days after infection of susceptible mice, the structure of the spleen was severely disrupted: the
boundary between red and white pulp regions became indistinct and within the white pulp it
was no longer possible to distinguish T-cell from B-cell regions. There were high levels of cell
multiplication and cell death, increased deposits of fibrin and marked production of red blood
cells and cells of the monocyte and polymorphonuclear leukocyte lineages (Figure 15).
Figure 15. Section through the red pulp of the spleen of a susceptible C3H/He mouse 7 days
after infection with T vivax. The micrograph shows cytolysis (C), fibrinous deposition (F) and
trypanosomes within the blood vessel (T).
When susceptible mice were infected with T brucei, damage to the spleen was less severe,
though the white pulp area was disrupted. The disruption of organ structure did not prevent
the development of antibody-producing cells, though these did not secrete antibody.
When susceptible mice infected with either T vivax or T brucei were treated with diminazene
aceturate, their spleen structure rapidly returned to normal and serum antibody responses
became detectable. 'Healthy' cells were produced in the spleen 16 hours after trypanocidal
treatment. This observation of rapid recovery after trypanocidal treatment indicates that the
disruption of spleen structure in infected mice is directly or indirectly related to the presence of
living trypanosomes or more likely to short-lived factors from degenerating parasites. Little or
no spleen disruption was observed in mice infected with monomorphic lines of T brucei, which
remain as dividing forms and grow exponentially until death of the host.
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To explore the mechanism(s) involved in spleen disruption, the numbers of cells of different
types were compared in the spleens of resistant and susceptible mice infected with T brucei or
T vivax. The major difference was that monocytes/macrophages were more numerous, larger
and contained more vacuoles in the spleens of susceptible mice than in resistant mice
infected with either parasite species. Because monocytes/macrophages can be a source of
proteases and free oxygen radicals—which can cause tissue damage—the function of these
cells is being investigated.
It remains possible that spleen disruption does not result directly from products of activated
host cells, but rather from the release of enzymes or other molecules by trypanosomes. If this
is the case, differences in host susceptibility to parasite components could be due to
differences in substrate polymorphisms or in the production of plasma inhibitors. Future
studies aim to clarify the link between lymphoid organ disruption and defective terminal
maturation of B cells in infected susceptible mice, and also to elucidate how these processes
are induced and how they contribute to the regulation of antibody responses in resistant mice.
Pathogenesis: effects of trypanosomiasis on bovine reproduction
A study was carried out in 1985 in collaboration with the Centre for Tropical Veterinary
Medicine of the University of Edinburgh (UK) to investigate the effects of T congolense
infection on the reproductive cycle of female Boran cattle. Two groups of six Boran cows were
infected with T congolense and treated with diminazene aceturate, 60 and 90 days after
infection respectively. Two groups of five control cows were not infected, but were treated with
diminazene aceturate at the same time as the infected animals. All the cows used in the
experiment had already completed at least one oestrous cycle.
Following infection, 1l out of 12 cows became acyclical and most showed impaired luteal
function, though no pathological structures were observed by rectal palpation. The one cow
which continued to cycle showed reduced levels of progesterone. All the infected cows
resumed cycling within 2 months after drug treatment. The control cows continued to cycle
normally throughout the experiment and no abnormal ovarian structures were observed,
indicating that treatment with diminazene aceturate had no effect on the oestrous cycle.
This experiment provided the first clear demonstration of the relation between T congolense
infection and reduced fertility in cattle. However, it was not possible to distinguish between the
direct effect of the parasites on ovarian activity and the effect of weight loss associated with
infection.
Epidemiology
Characterization of trypanosome populations
Research has been in progress for several years aimed at developing simple, accurate and
sensitive assays to detect trypanosomes in infected animals and tsetse and to identify parasite
species and serodemes. This work is important for diagnosis and the evaluation of treatment
as well as for epidemiological studies, for instance to predict the level of trypanosomiasis risk
in an area before introducing susceptible livestock or to determine the number of trypanosome
species or serodemes present in an area in order to assess the feasibility of controlling
trypanosamiasis by a 'cocktail' vaccine.
Serological typing: a common trypanosome antigen
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ILRAD scientists have demonstrated a protein with an apparent molecular weight of 83,000
daltons present in T b brucei, T congolense, T vivax, T b rhodesiense and T evansi. Studies
were earned out in 1985 to describe this protein more precisely. It accounted for 0.4 to 1.9 µg
per mg of total protein in all six trypanosome species and was shown by electron microscopy
to be associated with specific regions of the cell cytoplasm and with dispersed chromatin of
the nucleus. None of the protein was found on the plasma membrane or any other cellular
membrane. IgG antibody from antisera raised against this protein was found to be
monospecific: this monospecific polyclonal antibody will be used to screen trypanosome
expression libraries to identify clones producing the protein. If large amounts of the protein can
be produced, antibodies can be generated which will provide a useful tool for trypanosomiasis
diagnosis.
Serological typing: species-specific antigens
By the end of 1984, ILRAD scientists had derived monoclonal antibodies which recognized
antigens specific to the three major African trypanosome species. Used in a sandwich
enzyme-linked immunosorbent assay (ELISA), the monoclonal antibodies against T brucei and
T vivax detect circulating antigens in sera from infected cattle. The antibodies against T brucei
also detect antigens in sera from human sleeping sickness patients. In 1985, the T brucei
antibody was used successfully to detect trypanosomes in infected tsetse. The monoclonal
antibody derived against T congolense appears to recognize T simiae as well as T
congolense, but it is not yet sensitive enough to detect antigens consistently in the sera of
infected animals.
Present work involves isolating and purifying the species-specific antigens recognized by
these monoclonal antibodies. As with the common trypanosomal antigen, the goal is to screen
parasite DNA and identify clones which will produce these antigens for use in trypanosomiasis
diagnosis and epidemiological studies.
Serological typing: T congolense serodemes from Kilifi
Early work on T congolense showed that metacyclic forms of this species displayed a limited
number of VSGs which were serodeme specific. Subsequent efforts have concentrated on
developing serological methods for typing T congolense stocks on the basis of their repertoire
of metacyclic antigens. These studies started with 81 T congolense stocks isolated in 1982
from resident and tracer cattle on a large dairy farm at Kilifi in Kenya's Coast Province.
A total of 61 isolates were prepared from the tracer cattle, 40 of these were passaged and
cloned in mice, and 8 clones and 12 stocks were then transmitted through tsetse (G m
centralis). Metacyclic forms of the clones were screened by indirect immunofluorescence and
neutralization assays using anti-metacyclic hyperimmune sera. This work indicated that the
eight clones belonged to four distinct serodemes. Cross-challenge experiments in goats and
molecular karyotyping confirmed these results. Metacyclic forms of the 12 stocks were then
screened by immunofluorescence for reactivity with antisera against metacyclic forms of two of
the serodemes, revealing that each stock contained a mixture of serodemes.
This study indicates that serological typing of metacyclic trypanosomes can be used to identify
serodemes. It also suggests that the number of T congolense serodemes present on the Kilifi
farm may be limited. Analysis of sera from the tracer cattle showed antibodies against two of
the serodemes as early as 3 months after the animals were introduced on the site. This
suggests that exposure of susceptible cattle to tsetse challenge under certain conditions may
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lead to the development of acquired immunity against local trypanosome serodemes.
In vivo studies:
In studies earned out in 1985, stocks and clones of four T congolense isolates from Kilifi were
transmitted to goats by infected tsetse (G m morsitans). A T congolense stock (IL 1180)
originating from Tanzania was transmitted to control goats for comparison. The trypanosomes
originating from Kilifi did not produce significant chancres in the skin, compared with T
congolense (IL 1180), and infection with the Kilifi trypanosomes did not stimulate protective
immune responses against challenge with metacycic forms of the same stocks and clones.
These observations may be relevant to epidemiological studies of trypanosomiasis at Kilifi.
Use of genomic probes:
Developments in molecular biology have opened up new possibilities for characterizing
parasite species and population groups. Scientists at ILRAD are applying new techniques to
identify DNA hybridization probes for the classification of African trypanosomes. The
development of hybridization probes is particularly important for the identification of T
congolense as this species has demonstrated considerable genomic heterogeneity.
To produce a hybridization probe for trypanosome species identification, total genomic DNA
from one clone is hybridized at limited concentration for a short time with DNA from other
clones of the same species taken from different geographic areas. This results in the
identification of repetitive sequences common to all the clones used. The repetitive sequences
are then cloned in a phage or plasmid vector and used as hybridization probes in parasite
identification assays. Using this technique, specific DNA probes have been prepared at ILRAD
from T congolense ILNat 2.1, T brucei ILTat 1.4 and the West African T vivax IL 1392. These
probes have been used for the detection and identification of trypanosome infections in tsetse
flies.
The nucleotide sequence contained in the DNA fragment used as the T congolense probe was
examined in 1985. This fragment belongs to a class of DNA termed satellite DNA which has
no known function. Comparisons with satellite DNA from other trypanosome species showed
that this fragment is specific for T congolense and thus provides a useful marker for the
species. When tested against 5 samples of T b brucei, 5 of T b gambiense, 2 of T b
rhodesiense, 17 of T congolense, 2 of T evansi, 2 of T vivax and 2 of T simiae, the probe
hybridized with 15 of the 17 T congolense clones or stocks but with none of the other species.
The only T congolense samples not detected by this probe were two clones prepared from
trypanosomes obtained at Kilifi. A hybridization probe from the T congolense parasites isolated
at Kilifi was cloned and partially sequenced. This new probe should provide further evidence
of the relationship between the Kilifi trypanosomes and T congolense parasites from other
locations in Africa. A probe was also cloned in 1985 which hybridizes only with DNA from T
simiae, an important trypanosome species in pigs which is difficult to distinguish from T
congolense by other methods. The T brucei probe was sequenced in 1985, revealing that it is
not a fragment of satellite DNA but has the potential to encode a trypanosomal protein.
The sensitivity of the first DNA probes developed at ILRAD was tested in 1984 using
trypanosomes purified from diluted samples of blood. Work is still in progress to improve the
sensitivity of these tests. In 1985, the hybridization probes were tested against samples from
infected tsetse. The T congolense probe detected trypanosomes in the midgut of infected
tsetse following overnight exposure and in the proboscis after exposure of 5 hours. No
hybridization signal was observed in noninfected samples used as controls. The T brucei
probe detected infection in tsetse midgut and salivary gland samples after overnight exposure,
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but did not reliably detect parasites in the proboscides of infected tsetse even after exposure
for 1 week. The T vivax probe detected infection in over 70% of material taken from the
proboscides of infected flies.
A preliminary experiment suggested that the T brucei probe may detect as few as 200
trypanosomes/ml in infected cerebrospinal fluid. Results using the hybridization probe to
detect parasites in cerebrospinal fluid correlated with those obtained using other tests. One
advantage of using a hybridization probe for measuring parasitaemia in cerebrospinal fluid is
that this method detects both live and dead or fragmented trypanosomes.
The hybridization probes have been used to characterize a number of parasite samples
available at ILRAD. The T vivax probe derived from a West African stock (IL 1392) was shown
to detect East African isolates of this species less readily than isolates from West Africa. For
this reason, a hybridization probe has been developed which is specific for East African T
vivax, using DNA from a haemorrhagic T vivax isolate (IL 2337) from Kenya. A comparison of
DNA fragments from this isolate with DNA from the West African T vivax revealed clear
differences, and one fragment was identified from the East African parasites which may
provide a marker to discriminate between the two types.
During the screening of T congolense cDNA libraries to identify species-specific hybridization
probes, several other nucleotide sequences were identified. Preliminary results suggest that
two of these sequences, although their function is unknown, may prove to be useful reagents
to distinguish the three trypanosome subgenuses—Trypanozoon, Nannomonas and Duttonella
(Figure 16).
Figure 16. Hybridization of the recombinant plasmid pMLS with Rsa I digests of DNA from
different trypanosome species and subspecies. Lanes show DNA as follows: (1, 11) T vivax
ILDat 1.2; (2, 3, 4, 5) T congolense ILNat 2.1, ILNat 3.1, ILNaR 1, clone 776; (6) T b brucei
ILTat 1.1; (7) T b gambiense LiTat 1.6; (8) T b rhodesiense ETat 1.10; (9) T b brucei ILTat
1.4; (10) T evansi KETRI 2443 c1; (12, 13, 16, 17) T congolense AnNat 3.1, ILNat 3.1, ILRAD
2463 (from CRTA, Burkina Faso), ILNat 2.1; (14, 15) T congolense (Kilifi) ILNat 4.1, ILNat 5.1.
DNA fragment sizes are given in kb. This pMLS reveals fragments of DNA that are identical in
size in the trypanosomes that belong to one subgenus.
Once a trypanosome clone or isolate has been identified by hybridization with one of the DNA
probes available at ILRAD, it can be characterized further by hybridization with other,
independently cloned DNA sequences. Parasite clones may also be typed by comparing the
location of specific sequences on DNA molecules of different sizes, separated by enzymes
that digest DNA.
Separation by OFAGE of chromosome-sized DNA molecules from T congolense parasites
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isolated at Kilifi revealed similar patterns among clones shown by serological analysis to
belong to the same serodeme (Figure 17). It may be possible to use these patterns, referred
to as molecular karyotypes, to predict whether T congolense clones are likely to belong to the
same serodeme.
Figure 17. Variable molecular karyotypes in T congolense clones from different serodemes.
Chromosome-sized DNA molecules prepared from T congolense clones, each belonging to a
distinct serodeme, were resolved in a 1.5% agarose gel by OFAGE at 20-second pulse
intervals. After 15 h, the gels were stained and photographed. A: lanes 1, 2 and 3 contain
DNA from clones ILNat 2.1, ILNat 3.1 and C36. B: lanes 1, 2 and 3 contain DNA from clones
ILNat 3.1, ILNaR 1 (C57) and 776. C: lanes contain DNA as follows: (1) ILNat 4.1; (2) T (T)
brucei ILTat 1.1; (3) ILNat 5.1: (4) ILNat 3.1: (5) T.(T) brucei ILTat 1.1. (6) ILNat 2.1. ILNat 4.1
and ILNat 5.1 are derived from the Kilifi isolates, Clones of T congolense from different
serodemes have different molecular karyotypes. These, in turn, are distinctly different from the
molecular karyotypes of trypanosomes from different species, e.g. T brucei (lanes 2 and 5)
and the Nannomonas from Kilifi (lanes 1 and 3).
For T congolense ILNat 3.1, the results of molecular karyotyping have been shown to agree
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with crossresistance patterns in vivo. When goats were infected with T congolense of a
specific karyotype, they resisted challenge with T congolense of the same karyotype but were
susceptible to challenge with T congolense of other karyotypes, as shown by the development
or absence of chancres. These experiments also provided evidence that the molecular
karyotype may be a stable property of a specific trypanosome clone: no changes in
karyotypes were observed in trypanosomes cyclically transmitted to goats or cattle, even after
infection had been maintained in the animals' bloodstream for as long as 90 days.
Isoenzyme analysis:
In recent years, considerable genetic diversity has been shown to occur in some of the
currently recognized trypanosome species. Such diversity is revealed by detecting differences
in the electrophoretic mobility of certain enzymes. For instance, T b brucei parasites from East
and West Africa can be distinguished in this way, and isolates of T congolense from Liberia
have been shown to be distinct from T congolense parasites from other parts of West Africa.
In 1985, ILRAD scientists compared several stocks of Nannomonas trypanosomes from Kilifi
with groups of T congolense parasites originating elsewhere in Africa. Several enzymes from
the Kilifi isolates were shown to differ from enzymes of other T congolense parasites (Figure
18). All the Kilifi isolates which have been studied belong to a genetically distinct group of
parasites. Enzymes from Nannomonas trypanosomes isolated at Muhaka, approximately 100
km south of Kilifi, were also analysed: out of 25 isolates, 23 resembled groups of T
congolense which had previously been described, while 2 had enzymes characteristic of the
Kilifi parasites.
Figure 18. The electrophoretic mobilities of a peptidase enzyme from several isolates of
Nannomonas trypanosomes. Details of some of the isolates are (from left to right): lane 1, IL
1180 isolated from a lion in Serengeti, Tanzania; lane 2, IL 2411 isolated in West Africa; lane
3, isolated from Muhaka; Kenya; lanes 4 to 19, isolated from Kilifi, Kenya; lanes 20 and 21,
isolated from Muhaka, Kenya, possessing Kilifi-like enzymes; lanes 22 to 25, isolated from
Muhaka. Kenya; lane 26, mouse red blood cell; lane 27, IL 1180.
Tsetse flies as trypanosome vectors:
In a research project partially funded by the International Atomic Energy Agency (IAEA),
ILRAD scientists have shown that male tsetse sterilized by gamma-irradiation can transmit the
three major pathogenic trypanosome species as effectively as normal tsetse. Experiments
initiated in 1980 and completed in 1985 tested the vectorial capacity of sterilized males of
seven tsetse species and subspecies for East and West African stocks of T vivax, T
congolense and T brucei. Results, summarized in Figure 19, show very small and inconsistent
differences in the infection rates of irradiated and normal tsetse. These findings suggest that
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the release of large numbers of sterilized male tsetse as part of a tsetse control program could
increase the immediate risk of trypanosomiasis. This approach should thus be accompanied
by other, short-term measures to control infection in local livestock or human populations at
risk from trypanosomiasis.
 E African
vivax 
(IL 2241)
W African
vivax 
(IL 1392)
E African
congolense
(IL 2047)
W African
congolense
(IL 2281)
E African
brucei
(IL 923)
W African
brucei
(IL 2380)
G m centralis
Sterile 55.9 49.5 44.0 55.8 50.9 12.3
Fertile 61.1 46.3 35.3 49.2 40.4 6.8
G austeni
Sterile 4.2 50.0 0.0 2.1 1.0 0.0
Fertile 1.8 54.8 2.0 3.0 0.2 0.0
G p palpalis
Sterile 0.0 45.3 0.5 1.0 0.4 0.4
Fertile 0.0 39.9 0.5 0.7 0.4 0.0
G p gambiensis
Sterile 1.8 58.1 0.0 0.3 0.0 0.2
Fertile 1.3 62.8 0.3 0.3 0.4 0.0
G f fuscipes
Sterile 0.3 42.2 1.6 1.5 1.6 0.0
fertile 0.5 41.2 6.0 0.9 2.1 0.0
G tachinoides       
sterile 0.0 41.7 0.3 0.8 1.5 1.3
fertile 0.3 41.5 0.3 2.0 1.0 0.7
G brevipalpis
Sterile 69.7 75.4 18.3 8.8 0.0 0.0
Fertile 75.3 81.6 15.7 6.3 0.2 0.0
Figure 19. Infection rates (%) in seven species of mature male tsetse sterilized by gamma-
irradiation and fed on animals infected with T vivax, T congolense or T brucei stocks
originating from East or West Africa. All groups were compared with fertile controls.
Many field workers have suggested that only immature teneral tsetse could become infected
with trypanosomes and transmit infection to mammalian hosts. Based on this assumption, it
has been suggested that the release of mature sterilized tsetse might not increase the risk of
trypanosomiasis. To test this possibility, 30-day-old male and female G m centralis were fed
on a goat infected with T brucei, then maintained on a noninfected rabbit and dissected 30
days later to determine infection rates. Infection rates in mature tsetse were lower than in
teneral flies fed on the same goat, but were still high enough to imply a significant level of
disease transmission.
Experiments were also conducted in 1985 to investigate the effects of trypanosome infection
on the probing and feeding behaviour of tsetse. G m morsitans and G m centralis flies were
infected with T vivax, T congolense or T brucei and then allowed to feed on noninfected
rabbits or mice for 20 consecutive days. There were no significant differences in the frequency
of probing or feeding between any group of infected tsetse and noninfected controls. This
indicates that the presence of trypanosomes in the tsetse midgut, proboscis or salivary gland
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does not impair the feeding behaviour of the flies.
Further studies were conducted to investigate the effects of trypanosome infection on tsetse
survival and reproductive performance. Groups of teneral female G m morsitans were mated
and fed for 63 days on calves or goats infected with T vivax, T congolense or T brucei. Their
survival rates and the number and weight of puparia produced were compared with those of
female tsetse fed on noninfected calves or goats. Differences between tsetse maintained on
infected and noninfected hosts were small and inconsistent, suggesting that a high incidence
of trypanosome infection in mammalian populations probably does not have harmful effects on
tsetse.
It has been postulated that trypanosome infection rates in tsetse might be increased by
slowing the rate of movement of the parasites from the tsetse crop to the midget. To test this
possibility, groups of G m morsitans tenerals were fed on a goat infected with T brucei and
some were transferred to a cooler environment (20°C rather than the normal environment of
25°C) for 1 hour. This had the effect of slowing the movement of trypanosomes from the crop
to the gut. However, when surviving tsetse were dissected 35 days later, there was no
significant difference in infection rates between the different groups.
Work continued in 1985 to improve serological methods for identifying the source of tsetse
bloodmeals. First, antisera were derived which recognized many species at mammals or birds
from minute quantities of blood obtained from captured flies and preserved on filter papers.
Because it is difficult to standardize antisera, work now concentrates on deriving monoclonal
antibodies against mammalian family- or species-specific proteins. Monoclonal antibodies
were derived in 1984 and 1985 which recognize bloodmeal samples from cattle; goats and
sheep; domestic pigs, bushpigs and warthogs; eland; bushbuck; waterbuck; oryx; and the
Alcelaphinae family (wildebeest, hartebeest and topi). ILRAD scientists have made this
technology available to colleagues at the International Centre of Insect Physiology and
Ecology (ICIPE) and are analysing tsetse bloodmeal samples for the International
Trypanatolerance Centre in The Gambia and for ILCA/ILRAD trypanotolerance research
network sites in Central and West Africa, Ethiopia and Kenya.
In 1983, scientists at ILRAD purified a thrombin inhibitor from the saliva and salivary glands of
G m centralis and demonstrated its anticoagulant effect on tsetse bloodmeals. Fibrinalytic
enzymes were also identified in the tsetse midget which probably function as a back-up
mechanism to protect feeding tsetse from the potentially harmful effects of blood clotting.
Scientists employed several purification and assay systems in 1985 to characterize these
enzymes. Two enzymes have been identified and shown to be serine proteases. They consist
of single polypeptide chains with molecular masses between 25,000 and 30,000 daltons. The
responses of immune sera raised against the two enzymes show that they are closely related,
perhaps sharing some common antigenic determinants. Antibody responses to the enzymes
are being investigated in more detail; the goal is to determine whether antibodies against the
enzymes might be used to kill tsetse by blocking the breakdown of blood clots in the crop.
Livestock production under trypanosomiasis risk
Trypanocidal drugs: detection and testing in vitro
Although trypanocidal drugs have been widely used in Africa for more than 50 years, very few
are available commercially and no new compounds have been introduced on the market for
over 25 years. A major constraint on the development of new trypanocidal drugs for human
and veterinary use is the expense of drug testing on experimental animals. The testing of
existing trypanocidal compounds is also assuming increasing importance with the appearance
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of parasite populations showing a degree of drug resistance.
Trypanosome culture systems developed at ILRAD are being used to screen the effects of
trypanocidal drugs on different parasite species and stocks in vitro. This work is being carried
out in collaboration with the Swiss Tropical Institute. Although the activity of a trypanocidal
compound in the laboratory does not always correspond precisely with its effectiveness in the
field, the results of drug screening assays provide important insights into possibilities for
improved trypanosomiasis control. Drugs which are highly active in vitro but perform poorly in
livestock might become useful after modification of their structure or formulation. At the same
time, a drug which shows trypanocidal activity in vivo but not in vitro is likely to be
metabolized, and identification of the active metabolite involved could result in a more
powerful trypanocidal effect.
An in vitro assay system was developed originally using T brucei parasites cultured with
mammalian feeder layer cells. This assay measures the minimum drug concentration required
to inhibit trypanosome growth by more than 50% during 24 hours' exposure (IC50). Work in
1984 and 1985 has concentrated on simplifying and standardizing the assay system and
extending it to measure trypanocidal activity against T congolense and T vivax.
T brucei cultures can easily be initiated from tsetse-derived metacyclic farms or parasitaemic
blood. By contrast, bloodstream forms of T vivax and T congolense are maintained more
reliably after passing through the parasite lifecycle in vitro, so 'second generation' parasites
are used for trypanocide screening against these two species. Efforts to simplify T congolense
and T vivax cultivation by eliminating the requirement for feeder layer cells have not yet been
successful.
Seven trypanocidal compounds were tested against T vivax (IL 1392) in 1985 and the results
compared with their effects against T brucei (TC 221). The phenanthridines, isometamidium
chloride (Samorin: May and Baker) and ethidium chloride (Novidium: May and Baker), showed
higher activity against T vivax than against T brucei, while the effects of the diamidines,
diminazene aceturate and pentamidine isethionate (Pentamidine: May and Baker), were
similar for both species. The naphthalene, suramin (Naganol: Bayer), and the quinoline,
quinapyramine sulphate.(Trypacide: May and Baker), showed much higher activity against T
brucei than against T vivax. These results correspond with studies in vivo. Because of the
large number of parallel tests carried out on each drug, a computer program has been
developed at ILRAD for evaluating and analysing drug screening data.
Parasites exposed to drugs may be tested for infectivity as well as effects on their viability and
growth. When T congolense (IL 1180) parasites were exposed to isometamidium chloride for
24 hours at low drug concentrations, their growth was not inhibited but they lose their
infectivity for mice. The combination of these two parameters—inhibition of growth and loss of
infectivity—results in an assay system sensitive enough to detect trypanocidal activity in
samples from infected animals. When plasma samples taken from Boran cattle which had
been infected with T congolense and treated with isometamidium chloride were added to T
congolense cultures, the plasma killed the parasites or rendered them noninfective to mice.
Plasma taken after the cattle became susceptible to reinfection supported trypanosome
growth.
This in vitro assay is now being used to evaluate the effects on trypanosome viability and
infectivity of plasma and cerebrospinal fluid taken from goats which have been treated with
different trypanocidal compounds. High-performance liquid chromatography (HPLC) analysis
is being used in conjunction with the assay system in an attempt to quantify levels of
trypanocides in samples taken from treated animals.
Trypanocidal compounds must be extracted from plasma before they can be analysed by
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HPLC. Diminazene aceturate is recovered from plasma relatively easily and amounts in the
low µg range can be detected by HPLC. By contrast, extraction of suramin is more complex
because this compound binds with plasma proteins, so only larger amounts (approximately
200µg/ml) can now be detected accurately by HPLC. The detection of isometamidium chloride
in plasma samples is also complicated, due to the breakdown of this drug within the host into
active, as yet unidentified, metabolites. Current studies are directed towards identifying active
components in the plasma of treated animals which differ from the parent compound and
towards increasing the sensitivity of detection of trypanocides in biological fluids.
Drug levels in cerebrospinal fluid from treated animals can be measured directly by HPLC
without prior extraction. Analyses of cerebrospinal fluid concentrate particularly on the
detection of melarsoprol (Arsobal: Specia), the only commonly used drug known to cross the
blood-brain barrier in trypanocidal amounts.
Trypanocidal drugs: evaluation of protection:
Despite the wide use of trypanocidal drugs, very little is known about their mode of action in
vivo or the factors which may have an influence on the effectiveness of a therapeutic regime.
Such factors include drug dosage, level of trypanosome challenge, the effect of pre-existing
infection at the time of drug treatment and the possible development of immunity while under
chemoprophylactic cover.
An experiment conducted in 1984 showed that treatment with isometamidium chloride (1
mg/kg body weight) protected cattle against repeated challenge with T congolense (IL 1180)
for at least 5 months. Protection appeared to be afforded by the drug alone, as no
anti-trypanosome antibodies were detected in any of the animals which resisted challenge.
Group
Previous
challenge
Drug dosage
(mg/kg)
Challenge First infection (month)
Serodeme Method Animal:  1 2 3 4
A none 1.0 IL 1180 5 tsetse  5 6 - -
B none 1.0 IL 2642 5 tsetse  6 6 - -
C none 0.5 IL 1180 5 tsetse  4 5 5 -
D IL 2642a 0.5 IL 1180           5 tsetse  5 5 6 6
E none 0.5 IL 1180 5000 metacyclics  4 4 6 6
F none 0.5 IL 1180 500,000 metacyclics  4 5 5 7
aFive infected tsetse 4 weeks before treatment.
Figure 20. Effectiveness of isometamidium chloride treatment against T congolense challenge
in cattle. Twenty-four 1-year-old Boran steers were divided into six groups of four. All groups
were treated with isometamidium chloride (1.0 or 0.5 mg/ kg) and challenged with T
congolense (IL 1180 or IL 2326) monthly from 2 to 7 months after drug treatment. Challenge
was either by five infected tsetse flies (G m centralis) or by inoculation with 5000 or 500,000 in
vitro-derived metacyclic trypanosomes. Untreated controls were also challenged every month
to confirm the infectivity of the parasites.
In a second experiment conducted in 1985, 24 yearling Boran steers were treated with
isometamidium chloride and then challenged monthly with T congolense (IL 1180 or IL 2642)
from 2 to 7 months after drug treatment (Figure 20). Routine clinical examinations were
conducted throughout the period of the experiment. Parasitaemia was monitored after every
challenge by direct observation and subinoculation in mice. Breakthrough trypanosome
populations were tested for drug sensitivity in vitro and all cattle were checked for the
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development of anti-trypanosomal immune responses. Figure 20 shows the onset of infection
in all the treated animals.
Approximately 75% of the treated cattle, on becoming infected, exhibited less pronounced skin
reactions and less severe enlargement of the draining prefemoral lymph node than untreated
controls. Many treated animals also exhibited a delayed onset of parasitaemia and concurrent
anaemia. No trypanosomes from breakthrough infections showed any increased resistance to
the drug.
All four cattle challenged by inoculation with 500,000 in vitro-derived metacyclic trypanosomes
developed low but persistent levels of antibody against the parasites, yet they were still
susceptible to infection between 4 and 7 months after treatment. None of the other cattle
showed antibody responses during the period in which they were protected by the drug:
antibody titres were only observed at the time of onset of parasitaemia. The five animals which
remained refractory to infection at the end of the experiment produced no antibodies against
the parasites. Conclusions may be summarized as follows:
1. While the experimental results were similar in cattle infected with two unrelated
serodemes of T congolense, it is not possible to generalize about the situation in the
field where other populations of T congolense or populations of T vivax may differ in
terms of virulence or drug sensitivity.
2. Although the number of animals in the experiment was small, statistical analysis of
results indicated a direct relationship between drug dosage and the duration of
protection.
3. Prior infection (Group D) appeared to have no influence on the duration of protection or
the development of immunity.
4. Under the conditions of the experiment, no relationship was detected between the
duration of protection and the level of trypanosome challenge (Groups C, E and F).
5. During the period of chemoprophylactic cover, immune responses were only observed in
animals subjected to very high levels of repeated parasite challenge (Group F).
6. No evidence of drug resistance was observed. Breakthrough trypanosome populations
remained sensitive to isometamidium chloride at doses of 0.5 mg/kg as determined by in
vivo assay.
Present work concentrates on conditions which may govern the development of protective
immune responses in animals treated with trypanocidal drugs. An in vitro assay system
developed at ILRAD is being used to measure drug levels in plasma taken from treated
animals and to evaluate the drug concentration required for effective protection. This work is
being conducted in collaboration with the University of Glasgow (UK) and the British
Government's Overseas Development Administration (ODA).
A study conducted in collaboration with the Kenya Government's Veterinary Research
Laboratory and the Free University of Berlin (FR Germany) tested immunological methods for
evaluating the effectiveness of curative trypanocidal drug treatment in camels. Ten camels,
negative for antitrypanosomal antibodies at the beginning of the study, were infected with
clones of T evansi (KETRI 2443). They were treated 8 weeks later, five with suramin and five
with melarsoprol. Three camels, which served as positive controls, were infected but not
treated and two camels were negative controls.
Samples of blood and cerebrospinal fluid were taken from all animals on a regular basis up to
7 months after the initial infection and several types of analysis were earned out. Parasitaemia
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was monitored and IgM and IgG antibody levels were determined by micro-ELISA. The
camels were weighed periodically and examined for clinical signs of disease.
Infected camels showed the characteristic clinical signs of T evansi infection: emaciation,
anaemia and oedema. Although subinoculation in mice revealed parasites in the cerebrospinal
fluid of all infected camels before treatment, no clinical signs of central nervous system
involvement were observed. Treatment with melarsoprol appeared to clear the parasites and
no relapse infections occurred. Suramin, which has no trypanocidal activity in the central
nervous system, also appeared to provide an effective cure. One relapse infection in the
suramin-treated group was detected by mouse inoculation, but parasites were never observed
in the camel's bloodstream, nor were there any clinical signs of disease. Both IgM and IgG
antitrypanosomal antibodies increased after infection but IgG levels declined after treatment,
as shown by ELISA. This suggests that analysis by ELISA could provide a useful toot for field
diagnosis of trypanosomiasis in camels.
Studies on resistance to trypanosomiasis:
Field studies have established that the N'Dama (Bos taurus) cattle of West Africa are more
capable of controlling trypanosome infection and resisting clinical signs of disease than Zebu
(B indicus) cattle in Africa or the European taurine breeds. In 1985, ILRAD scientists began
intensive research on the mechanism(s) of N'Dama resistance to trypanosomiasis, using 10
N'Dama cattle brought from The Gambia by embryo transfer and born at ILRAD in 1984
(Figure 21).
Figure 21. N'Dama bulls of 18 months of age. These are five of the ten N'Dama cattle brought
to ILRAD by embryo transfer and born in 1984.
Groups of 10 N'Dama and 10 Boran cattle were matched at 12 months of age and an average
weight of 140 kg. Two control cattle were included in each group. The other 16 animals were
each exposed to eight bites of tsetse (G m centralis) infected with T congolense (IL 1180).
Skin thickness at the bite sites was measured daily for 21 days and skin biopsies were
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collected from four cattle in each group 5, 8, 12, 15 and 21 days after infection. PCV and
parasitaernia were determined daily for the first 4 weeks and thereafter twice a week up to 5
months after infection. Animals showing PCVs of 15% or lower were treated with diminazene
aceturate. All animals were examined clinically twice a week during the first 3 months and
thereafter at weekly intervals. White and red blood cells, platelets and reticulocytes were
counted and haemoglobin and white cell differentiation were measured. Body weights were
recorded weekly.
Chancres developed at all bite sites in both the N'Dama and Boran cattle. The average time to
maximum skin thickness was similar in both groups (Figure 22).
Skin reactions N'Dama Boran
Time to peak skin thickness (days) 10.00 ± 0.2 10.20 ± 0.6
Skin thickness on day 0 (cm) 0.79 ± 0.2 0.66 ± 0.2
Skin thickness at peak (cm) 1.60 ± 0.2 1.18 ± 0.3
Skin thickness increase (%) 102 79
Figure 22. Skin reactions in 1-year-old N'Dama and Boran cattle after challenge with G m
centralis infected with T congolense (IL 1181). Eight cattle in each group were exposed to
eight infected tsetse bites each. None of the cattle had any previous exposure to trypanosome
infection.
Parasites were detected in the blood of the N'Dama on average 1 day sooner than in the
Boran, and the first peak of parasitaemia was reached on average 1 day sooner in the
N'Dama. The level of first-peak parasitaemia was slightly lower in the N'Dama and from 40
days to 5 months after infection they showed consistently lower parasitaemia levels than the
Boran (Figure 23).
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Figure 23. Estimated average number of trypanosomes per ml of jugular blood from eight
N'Dama and eight Boran cattle infected with tsetse-transmitted T congolense (IL 1180). Six of
the Boran were treated with diminazene aceturate around day 50; none of the N'Dama
required treatment.
The PCVs of six of the eight Boran dropped to 15% between 25 and 50 days after infection
and these animals were treated with diminazene aceturate (Figure 24). The N'Dama and the
two untreated Boran showed the most severe anaemia 50 days after infection. At that time,
the average PCV for the N'Dama was 22% and for the Boran 18%. Afterwards the N'Dama
recovered gradually, reaching normal PCV levels by 120 days after infection though parasites
were still detectable in their blood.
To summarize the results of this study:
1. Reactions during the first 20 days after challenge with tsetse-transmitted T congolense
are similar in N'Dama and Boran cattle with no previous exposure to trypanosomiasis.
2. Boran cattle are likely to die from 20 to 50 days after T congolense infection unless
treated, while N'Dama start to control parasitaemia levels during this period.
3. N'Dama cattle begin to control anaemia about 25 days after infection with T congolense;
their PCVs start to rise by day 50 and reach normal levels by day 120 after infection
without treatment.
4. The growth of 1-year-old N'Dama cattle is retarded by 10 to 15% during 5 months of
infection with T congolense.
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Figure 24. Average PCVs of eight N'Dama and eight Boran cattle infected with tsetse-
transmitted T congolense (IL 1180). Six of the Boran were treated with diminazene aceturate
around day 50 when their PCVs fell to 15%; none of the N'Dama required treatment.
The group of eight infected N'Dama cattle will next be challenged with an unrelated serodeme
of T congolense. Their responses to this second challenge will be compared with reactions to
the first infection.
In 1985, ILRAD scientists studying trypanosome infection in wildlife compared skin responses
and antibody production in four buffalo and four susceptible cattle infected by tsetse with T
congolense (IL 1180). This work was conducted in collaboration with the Kenya Government's
Veterinary Research Laboratory partially supported by the Government of The Netherlands.
Skin reactions at the sites of infected tsetse bites were much less severe in the buffalo than in
the cattle, as indicated by changes in skin thickness. Trypanosomes were never observed in
histological sections of buffalo skin, though all four animals became infected. Severe collagen
destruction was observed in the skin of the cattle, but not in the buffalo. The skin reaction in
the buffalo was clearly diminishing 18 days after infection, but there were no signs of
regression in the cattle at that time.
Parasites were detected in the bloodstream sooner in the cattle (10 to 12 days after infection)
than in the buffalo (18 to 27 days after infection). Parasitaemia was considerably lower in the
buffalo and no parasites were detected after about 30 days. Serological analysis of blood
taken from the buffalo revealed antibodies capable of neutralizing T congolense metacyclics
as early as 15 days after infection. In three out of four of the buffalo, these neutralizing
antibodies were observed several days before parasites were detected in the bloodstream. By
contrast, a high level of parasitaemia appeared to be a prerequisite for antibody responses in
the cattle: neutralizing antibodies were first observed 25 days after infection, more than 10
days after parasites were detected in the blood. The pattern of resistance demonstrated by
buffalo in this study differed considerably from the resistance observed in N'Dama cattle in the
experiment reported above.
Trypanotolerance research network
ILRAD scientists are participating in a trypanotolerance research network coordinated by ILCA.
In 1985, the network included research sites in six countries of West and Central Africa—
Gabon, Zaire, Nigeria, Ivory Coast, Togo and The Gambia as well as associated research
projects in Kenya and Ethiopia. The goal is to obtain accurate, comparable information on the
health and productivity of different breeds of livestock in different ecological zones, under
different management systems and exposed to different levels of trypanosomiasis risk. Such
information is essential for the rational planning and evaluation of livestock development in the
region, including existing or new measures to control trypanosomiasis.
Attention is directed particularly towards the indigenous taurine cattle breeds of West Africa
which have shown resistance to trypanosome infection—the N'Dama and West African
Shorthorn. At most of the study sites, the health and productivity of these breeds can be
compared with that of susceptible cattle kept under the same conditions. The local breeds of
sheep and goats also demonstrate a degree of resistance to trypanosomiasis.
ILRAD's role has been to establish and support procedures to monitor tsetse populations,
trypanosome infection rates in tsetse and livestock and the health status of animals included in
the study. ILRAD also has primary responsibility for the introduction and evaluation of
trypanosomiasis control measures in the study areas. ILCA is responsible for animal
production and nutrition studies and for data processing.
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As an important contribution to the network, ILRAD scientists collaborate with ILCA staff in
conducting intensive training courses for field personnel. Normally two 7-week training
courses are held at ILRAD each year—one in French and one in English. By the end of 1985,
41 staff members working in the trypanotolerance network had received training.
Data have been collected in Gabon since 1981, covering trypanotolerant N'Dama and
susceptible Nguni cattle and their crosses. The study site is a government-operated ranch in
the humid forest zone. The ranch is infested with three tsetse species; trypanosome infection
rates are substantial in flies and in susceptible cattle (Figure 25). Cattle are maintained under
one of three treatment regimes: total prophylactic treatment, partial prophylaxis or curative
treatment when disease becomes apparent. A preliminary analysis of animal health data
collected over 2½ years revealed weight losses in infected cattle during periods when
noninfected animals were gaining weight. Further results, as shown in Figure 25, indicate that
the N'Dama were less likely to become infected, suffered less anaemia (with higher average
PCVs) and required trypanocidal treatment less frequently than susceptible cattle or
crossbreds.
Breed
Infection rate
(%) PCV level (%) Annual drug treatments
N'Dama 5 35 0.6
Nguni 27 28 4.4
Crosses 13 30 2.4
Figure 25. Indices of animal health in N'Dama (Bos taurus), Nguni (Bos indicus) and
crossbred cattle maintained under medium trypanosomiasis risk at Okouma Ranch in Gabon.
Infected cattle were treated with diminazene aceturate. Data are averages from observations
over a period of 2% years.
Studies began in 1983 on two large, privately owned cattle ranches in Zaire (Figure 26). At
Kolo Ranch, 25,000 N'Dama cattle are maintained in an area which is free of trypanosomiasis.
Research at this site will be completed in 1986 and should provide baseline productivity data
for comparison with N'Dama production under different management systems and levels of
trypanosomiasis risk. Mushi Ranch supports 16,000 N'Dama cattle in an area of substantial
trypanosomiasis risk. Some animals are treated with diminazene aceturate when
trypanosomiasis is observed. A third site in Zaire, a village production situation at Idiofa, was
added to the research network in 1985; N'Dama cattle were introduced to farmers in this area
in 1957. Animal health and productivity data from this site will provide a useful guide to
N'Dama production potential under a village management system.
Country and site
Tsetse Cattle
Species
Mean relative
density
Mean infection
rate (%) Breed
Number in
study
Mean monthly
infection rate (%)
Gabon
Moanda Ranch palpalis 0.30 20.2 N'Dama 900 5.0
tabaniformis 0.36 23.0 Nguni 100 27.0
nashi 0.06 8.8 Crosses 200 12.5
Zaire
Kolo
Ranch
palpalis 0.54 0.3 N'Dama 650 0.0
Mushi
Ranch
fuscipes 0.93 2.6 N'Dama 650 7.3
tabaniformis 5.28 11.2    
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Ivory Coast
Boundiali
Village
palpalis 0.61 20.5 N'Dama 50 14.7
tachinoides 0.26 20.4 WAS 300 13.9
morsitans 0.01 NA Zebu 20 32.8
   Crosses 200 19.5
Tengrela
Village
palpalis 0.94 4.2 N'Dama 40 3.0
tachinoides 0.07 10.4 WAS 30 2.7
   Zebu 10 3.9
   Crosses 300 3.5
Togo
Avetonou
Station &
Village
Palpalis 0.10 14.3(?) N'Dama 200 3.9
tachinoides 0.10 9.1(?) WAS 240 NA
   Crosses 60 NA
Figure 26. Tsetse infestation, cattle numbers and trypanosome infection rates in tsetse and
cattle at six trypanotolerance study sites in West and Central Africa. Tsetse density is
indicated by the average number of flies caught daily in each trap. WAS stands for West
African Shorthorn.
Research began in 1983 in two areas of Ivory Coast—Boundiali and Tengrela—in
collaboration with the Société d'Etat pour le Développement de la Production Animale
(SODEPRA: Ivory Coast) and the Gesellschaft für technische Zusammenarbeit (GTZ: FR
Germany). Local livestock producers maintain cattle and sheep under a seminomadic
production system (Figures 26 and 27). Relative tsetse density is similar in both areas, but
trypanosomiasis risk, as measured by tsetse infection levels, is much higher in Boundiali than
in Tengrela. Research is difficult for several reasons: the disease situation is complex,
including trypanosomiasis, tick-borne diseases, helminthiasis and the threat of rinderpest and
peste des petits ruminants (PPR); the animals do not stay in one place; and it is impossible to
record all trypanocidal drug treatment. However, research results from these areas should be
representative of production systems practiced over the broad semiarid region of West Africa.
Country and Site
Tsetse Livestock
Species
Mean
relative
density
Mean infection
rate (%) Species
Number in
study
Mean monthly
infection rate (%)
Nigeria
Fashola Palpalis 0.10 NA goat 175 3.5
tachinoides      
Ivory Coast
Boundiali Palpalis 0.61 20.5 sheep 240 7.4
tachinoides 0.26 20.4    
morsitans 0.01 NA    
Tengrela Palpalis 0.94 4.2 sheep 300 1.9
tachinoides 0.07 10.4    
Togo
Avetonou Palpalis 0.10 NA sheep 180 1.9
tachinoides 0.10 NA    
Sokodé Palpalis 0.04 NA goat 80 7.0
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tachinoides 0.59 4.0 sheep 200 4.1
Figure 27.Tsetse infestation, livestock numbers and trypanosome infection rates in tsetse and
small ruminants at five village sites in West Africa. Tsetse density is indicated by the average
number of flies caught daily in each trap. All goats are of the West African Dwarf breed; sheep
are Djallonké. Both breeds are considered to possess some resistance to trypanosomiasis.
In collaboration with the Centre de Recherche et d'Elevage (CREAT) and GTZ, network field
staff are monitoring cattle, sheep and goat production in two village areas of Togo-Avetonou
and Sokodé (Figures 26 and 27). Staff of the ILCA Humid Zone Small Ruminant Program also
collect data on the nutrition and health status of goats at four village locations in Nigeria.
Preliminary results are given in Figure 27.
ILRAD is cooperating with a project initiated in 1982 by the Kenya Ministry of Agriculture and
Livestock Development at Muhaka village near the Kenya Coast. Staff of the project are
measuring relative tsetse density in the area and monitoring the health and productivity of
about 500 East African Zebu cattle. Beginning in April 1984, two-thirds of the animals have
received prophylactic drug treatments 4 times a year; the others only receive curative
treatment as required. PCVs of cattle in the prophylactic treatment group averaged 27.2%
during the first year of treatment, compared to 26.4% for the others. On average, 3.1 % of
cattle under prophylactic treatment required curative treatment each month, compared to 8.1
% of the cattle without prophylaxis, and over the 12-month period average weight gains were
33% higher for cattle receiving prophylactic treatment.
A large-scale livestock development project was initiated in 1984 in The Gambia under the
auspices of the International Trypanotolerance Centre (ITC). ILRAD is collaborating with ILCA
and the ITC in the research component of the project, which began in 1985. Entomological
studies are supported by ODA, while the ILCA/ILRAD work on the productivity of N'Dama
cattle is funded by the EEC. The health and productivity of 2500 cattle are being monitored at
two village sites in The Gambia—Gunjur and Keneba—and two additional sites will be
included in the network, one at Bansang in The Gambia and one in Senegal. Scientists also
plan to study the mechanisms and genetic basis of trypanotolerance in N'Dama cattle and to
test new methods of trypanasomiasis control.
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Training and Information Services
Training
Information services
The ILRAD library
Training
ILRAD's training activities include individualized training programs for scientists and
technicians, post-graduate training for students working towards master's and doctoral
degrees, and post-doctoral positions for young scientists. In addition, training courses and
conferences are held each year. The emphasis is on developing veterinary research and
disease control capabilities in African countries where trypanosomiasis and ECF are important
animal health problems. Training activities account for nearly 10% of ILRAD's total budget.
In 1985, 17 scientists and technicians came to ILRAD on study attachments for periods of 2 to
16 weeks. Their training programs were planned on an individual basis according to the needs
of their home institutions. They came from 10 African countries—Burundi, Burkina Faso,
Ethiopia, Gabon, Kenya, Nigeria, Senegal, Uganda, Zambia and Zimbabwe. Two were
associated with national universities in their home countries, five were staff members working
with the ILCA/ILRAD trypanotolerance research network and the other ten were laboratory
technicians in national veterinary research organizations.
Post-graduate students work as Research Fellows at ILRAD from 1 to 4 years to fulfill
requirements for a post-graduate degree. Eighteen Research Fellows worked with ILRAD
scientists in 1985 on projects closely linked with the research program. Four Visiting Research
Fellows worked at ILRAD for shorter periods during the year. Four Research Fellows were
working towards master's degrees, one towards a diploma in veterinary science and the rest
towards their doctorates. Two of these were sent overseas to complete their degree training.
During the year, three Research Fellows were awarded their degrees. Research Fellows in
1985 came from Ghana, Kenya, Nigeria, Tchad, Uganda, Zaire, Belgium, Italy, Germany (FR),
The Netherlands, the UK and the USA. The students from Africa were fully or partially
supported by ILRAD, while the students from elsewhere were supported by funds from their
home countries.
Post-Doctoral Fellows are recruited on an international basis. They work at ILRAD for 2 years
on projects contributing directly to the research program. In 1985, 13 Post-Doctoral Fellows
were working at ILRAD—comprising 5 from the USA, 2 from Kenya and 1 each from Belgium,
France, Germany (FR), Japan, Rwanda and the UK.
A new training program component was added in 1985 designed specifically for young
scientists working in developing countries, principally in Africa. Under this program staff
members of universities or research institutes come to ILRAD for periods of 6 to 12 months to
work as Senior Research Fellows. The first Senior Research Fellow came to ILRAD in 1985
from the Biochemistry Department of the University of Nairobi.
In addition to training activities for individuals, ILRAD staff conducted three training courses in
1985. A 3-month course was held from September through November on the preparation and
use of reagents for the diagnosis of bovine haemoprotozoan diseases. Six participants
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attended this course from Burundi, Kenya, Senegal and Zambia.
Two courses were conducted in connection with the ILCA/ILRAD trypanotolerance research
network. A 7-week course was held in April and May with six participants from Ethiopia,
Mozambique, The Gambia and Zaire. This was the seventh course conducted for network
staff. As in previous courses, the subject was the diagnosis and control of trypanosomiasis,
helminthiasis and tick-borne diseases. The major emphasis was on practical aspects of clinical
diagnosis, collection and analysis of diagnostic materials and post-mortem examination of
cattle and goats. Training in animal production research focused on data recording and
analysis. The course also covered tsetse fly identification, ageing and dissection,
determination of trypanosome infection rates and collection and preparation of tsetse
bloodmeal samples. Participants practiced tsetse trapping techniques in the Kibwezi Forest. A
2-week course was held in June designed to upgrade the standard of tsetse research at
network sites. Four participants took part from Benin, The Gambia and Togo.
An international workshop on parasite antigens was held at ILRAD in May 1985, bringing
together 14 distinguished scientists from around the world to discuss their work with scientists
from ILRAD, ICIPE, the Universities of Nairobi and Yaoundé (Cameroon), the Kenya
Veterinary Research Laboratory and Trypanosomiasis Research Institute and the Uganda
Trypanosomiasis Research Organization. The objective of the workshop was to review the
current status of research aimed at characterizing, producing and utilizing parasite antigens for
improved disease control. Constraints on research were also discussed, as well as new
approaches towards the improved control of parasitic diseases. ILRAD's Information Services
published a summary of the discussions.
A second international workshop was held in September to discuss the implementation of ECF
immunization programs in East and Central Africa. This meeting followed up a joint
ILRAD/FAO workshop on ECF immunization held in October 1984. The 1985 workshop
covered methods of ECF immunization and the collection and analysis of data on the
productivity of immunized cattle. Sessions on data management and economic evaluation
techniques included practical demonstrations using microcomputers. Twenty-four invited
participants attended, representing research organizations, field projects and national
veterinary services in Burundi, Kenya, Malawi, Zambia and Zimbabwe. A report on the
workshop was published in 1986.
Seminars are given by ILRAD scientists and visiting researchers throughout the year,
presenting the results of ongoing projects. Altogether, 30 seminars were given in 1985,
including a special symposium on the characterization of trypanosome isolates from Kilifi,
Kenya. These gatherings are well attended by ILRAD staff and scientists from other research
institutions in the Nairobi area.
ILRAD provided financial support for two scientists, from Ethiopia and Zaire, to attend the Fifth
Annual Seminar on Tsetse and Trypanosomiasis Control, held in February and March 1985 in
Harare, Zimbabwe. The seminar was sponsored by the OAU, FAO and WHO. ILRAD also
supported two participants, from India and Nigeria, who attended the Seventh International
Congress of Protozoology, held in June 1985 in Nairobi. In addition, ILRAD provided
registration fees to cover participation in the Congress for 18 Kenyan scientists and students.
ILRAD makes its conference facilities available for a variety of workshops and seminars
sponsored by other organizations. The most important of these meetings held at ILRAD in
1985 were a Research Coordination Meeting on Sheep and Goat Production sponsored by
the International Atomic Energy Agency (IAEA), the annual general meeting of the Kenya
Veterinary Association, a regional Germplasm Training Course conducted by the International
Potato Centre (CIP), a Workshop on Animal Nutrition sponsored by the University of Nairobi,
and a major internal review of the ILCA/ILRAD trypanatolerance research network.
chapter3
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad85/chapter3.htm[5/19/2016 3:27:46 PM]
Information services
The primary activities of ILRAD's Information Services are the publication and distribution of
the annual report and the quarterly newsletter, ILRAD Reports, in English and French. A
weekly Internal Newsletter is also published in English and Kiswahili for distribution to staff
members and the Board of Directors.
Two updated brochures were published in 1985 describing ILRAD's training and research
activities. These are intended for wide distribution. In addition, a proceedings volume was
published—Immunisation against theileriosis in Africa—which includes papers and
discussions presented at the joint workshop sponsored by ILRAD and FAO in October 1984.
The summary proceedings of an international workshop on parasite antigens was also
produced for the workshop participants who came to ILRAD in May 1985.
The four issues of ILRAD Reports published in 1985 included major articles on the structure
and function of the bovine immune system; collaborative studies on trypanotalerant livestock;
international research on parasite antigens aimed at developing improved vaccines and
diagnostic tests; and detailed studies at ILRAD on the immune and nonimmune mechanisms
of host resistance to trypanosomiasis. Shorter articles described the workshop on ECF
immunization held in September 1985 and the establishment and institutional setting of ILRAD
within the CGIAR.
Members of ILRAD's scientific staff published 32 articles in international journals in 1985 and
16 chapters or scientific reports. These scholarly publications, plus numerous papers
presented at international conferences, comprise the bulk of ILRAD's information output for
specialized scientific audiences. The information section continues to direct considerable effort
towards ensuring the distribution of these publications to scientists in developing countries who
may not have access to a wide range of international journals.
The annual report and quarterly newsletter are intended for less specialized readers, with
emphasis on animal health workers in laboratories and field situations in Africa. In addition,
ILRAD Reports and occasional short press releases are distributed to journalists in many parts
of the world. A major effort was initiated in the second half of 1985 to verify and update the
distribution list for these publications (Figure 28). The goal is not simply to expand ILRAD's
audience, but rather to increase the accuracy and appropriateness of information distribution.
A major consideration, under continuous review, is the cost-effectiveness of production and
distribution of ILRAD publications.
Region
Countries Institutions/individuals
1984 1985 1984 1985
Anglophone Africa 26 24 749 851
Francophone Africa 24 24 334 378
Anglophone & other Europe 17 20 270 286
Francophone Europe 2 2 39 42
North & South America 27 27 304 317
Near & Far East 34 34 334 248
Total 130 131 2030 2122
Figure 28. Comparison of ILRAD Reports distribution at the end of 1984 and the end of 1985.
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The ILRAD library
The ILRAD library serves staff members, visiting scientists, participants in the training program
and staff of other research institutes, government departments and universities in Kenya. A
brochure, The ILRAD library: user's guide, describes the services offered.
The specialized collection concentrates on topics related to ILRAD's research program. The
library subscribes to 210 scientific journals covering fields such as parasitology, immunology,
biochemistry, entomology, cell biology and veterinary medicine and including several indexing
and abstracting journals. Journal subscriptions are reviewed every year according to the
recommendations of the scientific staff. The collection of scientific reference books is steadily
expanding: 401 new books were acquired in 1985, bringing the total to just over 3000.
The ILRAD library participates in an interlibrary loan network along with the University of
Nairobi, the Kenya Government's Veterinary Research Laboratory, the Veterinary Research
Department of the Kenya Agricultural Research Institute, the Ministry of Health and ICIPE. In
1985, ILRAD staff members borrowed 400 items from these other libraries, and the ILRAD
library loaned out 215 items through the network. In addition, the ILRAD library donated over
200 books and 15 journal volumes to other libraries in the Nairobi area.
The ILRAD library offers current awareness services through weekly announcements of
accessions in the Internal Newsletter and through subscriptions to three monthly selective
dissemination of information services. These are provided by Biosciences Information
Services (BIOSIS), the International Information System for Agricultural Sciences and
Technology (AGRIS) of FAO and the abstracts service of the Commonwealth Agricultural
Bureaux (CAB). In addition, the library carries out computer-based literature searches for
ILRAD staff using agents in Europe and North America.
The library orders copies of scientific articles not available in Kenya as requested by ILRAD
staff members. About 400 articles were acquired in 1985, mainly from the British Library
Lending Division. Reprints of scientific articles by ILRAD staff are supplied on request to
researchers and field workers in developing countries.
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Research Support
Tsetse laboratory
Tick laboratory
Farm animal production
Laboratory animal production
Clinical and diagnostic services
Tsetse laboratory
A great deal of the trypanosomiasis research conducted at ILRAD requires parasites which
have developed in tsetse flies. Although it is possible to maintain trypanosomes in vitro and to
infect laboratory animals and livestock by injection, the parasites normally pass through
several stages of their lifecycle in tsetse flies and trypanosomes maintained and transmitted
artificially are different in some respects from parasites transmitted through the bite of an
infected fly.
The three major taxonomic groups of tsetse flies—morsitans, palpalis and fusca—are
represented by seven breeding colonies maintained at ILRAD. These are Glossina morsitans
centralis originating from mainland Tanzania, G austeni from Zanzibar, G palpalis palpalis from
Nigeria, G p gambiensis from Burkina Faso, G fuscipes fuscipes from the Central African
Republic, G tachinoides from Tchad and G brevipalpis from Kenya. The overall breeding
performance of the seven colonies in 1985 is shown in Figure 29.
 Breeding
females
(mean)
Daily female
mortality 
(mean %)
Weekly pupae per
female (mean)
Puparial 
weight 
(mean mg)
Annual number
puparia
G m centralis 9566 0.44 0.54 33.68 269,584
G austeni 2240 0.15 0.43 25.81 50,374
G p palpalis 1991 0.54 0.41 30.01 41,934
G p gambiensis 2473 0.46 0.47 28.93 60,739
G f fuscipes 1787 0.31 0.45 34.58 41,492
G tachinoides 1857 0.76 0.49 19.29 47,009
G brevipalpis 5238 1.06 0.46 73.06 125,456
Figure 29. Performance of seven tsetse breeding colonies maintained at ILRAD in 1985.
All breeding colonies are maintained at 25°C; tsetse in the morsitans group are kept at 70%
relative humidity and the others are kept at 85%. All groups feed 5 days a week on rabbits. No
major production problems were encountered in 1985.
Tsetse flies are used in a wide range of trypanosomiasis research projects at ILRAD. In 1985,
tsetse puparia and adult flies were also supplied to scientists at the University of Nairobi, the
Kenya Agricultural Research Institute, the National Council for Scientific Research and an
FAO project in Zambia, the Universities of Bristol and Salford (UK), the Institute of Tropical
Medicine (Belgium) and the Swiss Tropical Institute.
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Tick laboratory
Infective sporozoite forms of T parva can only be obtained by continuous passage of parasites
between tick vectors and mammalian hosts. The tick laboratory at ILRAD maintains colonies
of infected and uninfected ticks by feeding on rabbits and cattle. The laboratory provides ticks,
tick organs and tick-derived Theileria sporozoites for a wide range of ECF research projects.
About 8.5 million ticks were raised in 1985 to provide a continuous supply of material for
research on ticks and tick-borne diseases. Whole ticks were provided to ILRAD scientists and
about 111,000 ticks were dissected to provide parasite material.
The main tick species maintained at ILRAD is Rhipicephalus appendiculatus, the principal
vector of T p parva and T p lawrencei. Colonies are maintained of several R appendiculatus
laboratory strains as well as field isolates from different locations in East Africa. A number of
other tick species are maintained in smaller colonies. These include Amblyomma variegatum
and A gemma, the vectors of Cowdria ruminantium (heartwater) and two relatively benign
Theileria species, T mutans and T velifera; Boophilus decoloratus and B microplus which
transmit Babesia spp and Anaplasma marginale; and Rhipicephalus evertsi evertsi and R
pulchellus.
Factors affecting tick survival and growth are investigated on a continuous basis, including the
development of host resistance to ticks, tick toxins causing paralysis or death of host animals,
residual effects on ticks of host acaricide treatment, toxic effects on ticks of substances in the
host diet, climatic and seasonal effects and bacterial and fungal diseases in ticks. Factors are
also studied which affect the development of Theileria parasites in ticks, including
characteristics of specific parasite and tick strains, individual and breed characteristics of host
cattle, timing of tick attachment, seasonal factors and the environment during tick feeding and
incubation. The goal is to provide the best dietary and environmental conditions for producing
large, healthy ticks which in turn are infected with the highest possible number of Theileria
sporozoites.
Experiments were conducted in 1985 to test whether Theileria infection rates could be
significantly increased in ticks fed on cattle whose immune responses are suppressed, either
by treatment with glucocorticoids or by splenectomy. Very high infection rates were achieved,
but results were strongly influenced by the reactions of individual cattle and by the Theileria
strain used.
Other studies concentrate on developing staining techniques to identify different Theileria
species in the salivary glands of infected ticks. Methods are also being investigated to assess
parasite maturation in the tick salivary gland.
The tick laboratory identifies ticks sent in by field workers from Kenya and other African
countries and supplies ticks and tick-derived parasite material to a variety of collaborative
research projects. In 1985, ILRAD's tick laboratory provided assistance to national veterinary
laboratories in Kenya, Rwanda and Zaire, two development projects in Kenya, the National
Tsetse and Trypanosomiasis Control Project in Somalia, the Serengeti Research Station in
Tanzania, Kenyatta University (Kenya) and the University of Oklahoma (USA). During the
year, field and laboratory workers came to ILRAD from Burundi, Ethiopia, Mozambique, The
Gambia and Zaire for training courses which included tick handling and identification and the
diagnosis and treatment of tick-borne diseases.
Farm animal production
Livestock production and management returned to normal in 1985 after a severe drought in
1984, both on the ILRAD farm at Kabete and on the ILRAD ranch, Kapiti Plains Estate. During
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the year, 427 cattle, 564 goats and 13 sheep were allocated for experimental purposes. Sixty
percent of the cattle were used for ECF research, 35% for trypanosomiasis research and 5%
for the production of antigens used by the diagnostic laboratory. Nearly all the small ruminants
were used for trypanosomiasis research.
The Kapiti ranch continued to supply nearly all the cattle required for ILRAD's research
program. From a breeding herd of 1,252 cows and heifers, 1,029 calves were born during the
year, resulting in a calving rate of 82%. The ranch supplied 331 Boran calves, 38 Guernsey
calves and 34 Boran steers to ILRAD and sold 328 cattle to other users. Apart from a few
sheep and goats born on the ILRAD farm at Kabete, all small ruminants used for experimental
work are purchased from local farmers.
Development of the Kapiti ranch in 1985 included the construction of fencing, water troughs
and an effluent storage tank. The addition of nearly 50 km of fencing has improved the control
of grazing and stock movement. A foundation herd of registered Boran cows is being
developed from the total herd of about 2500 animals, with selection based on conformation
and weight at 2 years old: sires for future breeding programs will be selected from the
progeny.
Embryo transfer work was initiated at the Kapiti ranch in 1984 to produce Boran calves of
specific BoLA types using selected BoLA-typed cows and bulls. The first Boran calves
produced by embryo transfer were born in 1985. The goal is to produce 50 to 60 calves by
embryo transfer each year, including single births, twins and chimaeric twins.
Brief outbreaks of salmonellosis and contagious caprine pleuropneumonia (CCPP) occurred
on the Kabete farm during the year, but were quickly controlled. An outbreak of
foot-and-mouth disease near the Kapiti ranch interrupted the supply of calves to ILRAD for a
short period.
Laboratory animal production
The laboratory animal unit provides a regular supply of rats, mice and rabbits for experimental
work at ILRAD and maintains small colonies of meadow voles (Microtus montanus), guinea
pigs and gerbils. All laboratory animals are housed and maintained according to international
animal welfare conventions.
Figure 30 shows the total number of rats, mice and rabbits produced and used in 1985. The
demand for mice increased by 50% over the 1984 level, the demand for rats dropped by 25%
and the demand for rabbits remained constant.
Species and strain Number weaned
Number supplied to
scientists
Rats 20,400 13,075
Mice
random-bred Swiss 25,573 16,538
inbred BALB/c 17,090 16,709
inbred C3H/He 6,589 5,430
inbred C57BI/6 5,419 4,107
others (purchased)  5,125
Rabbits 420 1,288
Figure 30. Rats, mice and rabbits produced in 1985 and supplied to ILRAD scientists.
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Random-bred rats raised at ILRAD originate from the Sprague Dawley strain. They are used
primarily for the production of trypanosomes. In addition, batches of two inbred rat strains
were imported in 1985 for specific experiments.
Mice are used primarily to study the mechanisms of resistance to trypanosomiasis, with
different strains varying in their susceptibility to trypanosome infection. Random-bred Swiss
mice are used for a great deal of experimental work, but colonies of three inbred strains—
BALB/c, C3H/He and C57B1/6—are required for some studies. Small colonies of C3H/HeJ,
AJ and DBA/2 mice were also maintained in 1985, and F1 and F1-back crosses were
produced of BALB/c × Swiss and C3H/He × C57B1/6. Batches of C57B1/6 beige and NZB
mice were imported for experimental use, as well as batches of two athymic nude strains,
D3H/Tif nude and C57B1/6 nude.
An isolation system is being established for laboratory animals, with three isolation units
already functioning. Imported animals can now be maintained in isolation with little or no risk
to the main breeding colonies. Virus-free batches of ILRAD's primary inbred strains were
imported in 1985; these are maintained in isolation units under sterile conditions.
Rabbits are used at ILRAD primarily to produce antisera and to support the tsetse fly and tick
colonies. The rabbit breeding colony slowly increased during the year, though rabbits must still
be purchased from outside breeders to meet the demands of the research program.
Preweaning losses in the rabbit colony may be attributable to poor natural ventilation. More
powerful ventilator fans have been installed in the breeding rooms and some rabbits are being
kept under sheltered conditions outdoors.
In addition to supplying nearly all the laboratory animals used at ILRAD, the breeding unit
provides mice, rats and other rodents to several organizations in Kenya. In 1985, these
included ICIPE, the Kenya Trypanosomiasis Research Institute, the Kenya Medical Research
Institute, the Institute for Primate Research, the Biochemistry Department of the University of
Nairobi, the National Museums of Kenya, the Kenya Society for the Protection and Care of
Animals and several Kenyan secondary schools.
Clinical and diagnostic services
The diagnostic laboratory carries out several types of routine analysis required by ILRAD's
research programs and animal production facilities. In 1985, a total of 37,804 samples were
analyzed. These comprised 26,341 serological samples, 4728 bacteriological samples, 3108
haematological samples and 3627 helminthological samples—altogether an increase of 26%
over the number of samples analysed in 1984.
Nearly all this expansion was due to the increased number of serological analyses required for
ILRAD's collaborative ECF immunization field trials. The diagnostic laboratory analyses
Theileria isolates collected from the field and checks cattle for previous exposure to ECF and
other diseases before they are immunized by infection and treatment. After cattle are
immunized, they are monitored for immune responses to Theileria parasites on a monthly
basis for 1 year.
Serum samples from farm and laboratory animals are screened for antibodies to six
bloodstream parasites—Theileria parva, T mutans, Trypanosoma brucei, T congolense, T
vivax and Anaptasma marginale. Most routine screening for Theileria and Trypanosoma
species is by the indirect fluorescent antibody (IFA) test. The ELISA test is also used to screen
bovine sera for antibodies to Trypanosoma species.
A new method for purifying antibodies against A marginale was developed in 1984. Work is
chapter4
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad85/chapter4.htm[5/19/2016 3:27:46 PM]
still in progress to produce defined antigen(s) for the diagnosis of A marginale in collaboration
with Washington State University (USA).
A major achievement in 1985 was the adaptation of the ELISA test for screening antibodies
against Babesia bigemina. Monoclonal antibodies have been generated against this parasite
which will be used to purify antigens for use in diagnosis.
In addition to services to ILRAD scientists, the diagnostic laboratory provided antigens,
conjugates and control sera to the Veterinary Research Department of the Kenya Agricultural
Research Institute, the University of lbadan (Nigeria), FAO projects in Burundi, Zambia and
Zimbabwe and a British Government (ODA) project in Tanzania. The diagnostic laboratory
also analysed sera collected from cattle in ECF areas for the Kenya Ministry of Agriculture and
Livestock Development and FAO projects in Zimbabwe and Tanzania.
The diagnostic laboratory offered a 3-month training course in 1985 on the preparation of
reagents for use in the serodiagnosis of bovine haemoparasites. Six specialists participated in
the course from Burundi, Kenya, Senegal and Zambia. In addition, eight laboratory technicians
and field veterinarians from developing countries received training in ILRAD's diagnostic
laboratory in 1985 on an individual basis.
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Financial statements
Rattansi Educational Trust Building
Koinange Street
P.O. Box 41968
Nairobi, Kenya
Telepones: 20891, 20418, 21244
Telex: 22140 CHUNGA
Cables: PRICEWATER
Price Waterhouse
Report to the Directors of the International Laboratory for Research on Animal Diseases
(ILRAD)
We have reviewed the abridged financial statements set out in Figures 31 to 34 which contain
information extracted from the accounting records of ILRAD for the years ended 31 December
1985 and 1984.
We confirm that the information set out in the abridged financial statements is consistent with
that contained in the audited financial statements for the years ended 31 December 1985 and
1984, on which we expressed an unqualified opinion.
Certified Public Accountants
14 March 1986
 1985 1984
Research
Parasitology-Trypanosomiasis 432 315
Biochemistry 656 727
Cell Biology 466 541
Immunobiology 357 356
Parasitology-Theileriosis 516 527
Pathology 605 598
Tsetse Laboratory 297 279
Tick Laboratory 124 106
Electron Microscopy 148 150
Total Research 3601 3599
Research Support
Office of Director of Research 416 562
Farm Animal Production 614 623
Laboratory Animal Production 148 133
Clinical and Diagnostic Services 72 86
Radioisotope and Central Core Services 341 303
Total Research Support 1591 1707
Training and Conferences 752 685
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Library and Information Services 369 313
Administration
Board of Directors 83 91
Office of the Director General 394 348
Finance 332 342
Personnel 74 85
Purchasing 302 275
Total Administration 1185 1141
General Operations   
Engineering 660 572
Transport 214 252
Services 228 146
Food and Housing 5 14
Stores 48 52
Total General Operations 1155 1036
External Program Review 125 -
Contingency - 10
Total Core Costs 8778 8491
Figure 31. Summary costs by program and activity (US$'000).
 1985 1984
Unrestricted Funds
United States Agency for International Development
(USAID)
2490 2500
World Bank (IBRD) 1200 1570
Canadian International Development Agency (CIDA) 686 699
United Kingdom 546 468
Germany (Federal Republic) 528 556
Switzerland 415 437
Australia 281 208
Netherlands 249 264
Sweden 237 197
Norway 234 255
Japan 201 150
Italy 164 112
Belgium 135 229
France 61 59
Denmark 47 -
Saudi Arabia - 300
Total Unrestricted Funds from Donors 7474 8004
Restricted Funds
United Nations Development Program (UNDP) 690 639
Italy 500 500
Belgium 110 105
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Total Restricted Funds from Donors 1300 1244
Total Unrestricted/Restricted Funds from Donors 8774 9248
Figure 32. Summary of core operating funds from donors (US$'000).
 1985 1984
Sources
Core Operating Funds
Unrestricted
Unrestricted Funds from Donors 7474 8004
Balance From Previous Year - -
Earned Income Applied in Year 289 144
Total Unrestricted Operating Funds 7763 8148
Total Restricted Operating Funds 1300 1244
Total Unrestricted/Restricted Operating Funds 9063 9392
Transfer to Capital Funds (285) (482)
Net Unrestricted/Restricted Operating Funds 8778 8910
Capital Funds
Transferred from Core Operating Funds 285 482
Unexpended Balance from Previous Year 419 -
Balance of Working Funds from Previous Year 778 687
Balance of Revolving Fund from Previous Year 100 100
Total Capital Funds 1582 1269
Special Projects
Wildlife 167 236
Trypanotolerance 137 -
Total Special Projects 304 236
Total Sources 10664 10415
Applications
Core Operations 8778 8491
Capital 426 391
Special Projects 304 236
Unexpended Balance
Unrestricted Core 278 419
Working Funds 778 778
Revolving Fund 100 100
Total Funds 10664 10415
Figure 33. Summary of sources and application of funds (US$ '000).
 1985 1984
Assets
Fixed Assets
Land and Building 10125 9882
Research Equipment 5040 4875
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Other Assets 1943 1871
Subsidiary Company
Investment 1786 1728
Long-term Loan - 58
Total Fixed Assets 18894 18414
Revolving Fund
Loans 93 86
Cash 7 14
Total Revolving Fund 100 100
Net Current Assets 1056 1197
Total Assets Employed 20050 19711
Fund Balances 18894 18414
Capital Fund
Working Fund 778 778
Unrestricted Core Surplus 278 419
Revolving Fund 100 100
Total Funds 20050 19711
Figure 34. Balance sheet as at 31 December 1985.
ILRAD
Published in 1986
Compiled and designed by S.B. Westley
Cover photo by D. Elsworth
Photos by D. Elsworth, S. Ito, F. Shikhubari, P. Webster
Typeset by Waldman Graphics
Printed by English Press
Nairobi, Kenya

